Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2578 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 Exploration of the Raven APM - NART discrepancy as a measure of intellectual decline Nys, Gudrun
2011
7 4S p. S273-
1 p.
artikel
1002 Exploring life history collage exposure on personhood and person-centered nursing home dementia care Buron, Bill
2011
7 4S p. S637-
1 p.
artikel
1003 Exploring the link between hypertension and dementia: Effects of blood pressure variability on brain perfusion and cognition in an elderly population Sijbesma, Jaap
2011
7 4S p. S598-
1 p.
artikel
1004 Exploring the specificity of small molecules exhibiting anti-Abeta aggregating activity Dahlqvist, Camilla
2011
7 4S p. S384-
1 p.
artikel
1005 Expression of Alzheimer-like pseudophosphorylated tau at Thr212, Thr231 and Ser262 induces a behavioral defect in drosophila melanogaster Alaniz, Maria Eugenia
2011
7 4S p. S515-
1 p.
artikel
1006 Expression of glutamate-related proteins vGlut1 and PSD-95 changed in a transgenic mouse model of Alzheimer's disease van der Stelt, Inge
2011
7 4S p. S147-
1 p.
artikel
1007 Expression of IL-1β and TNF-α in Alzheimer's pathology in mice Finsen, Bente
2011
7 4S p. S685-
1 p.
artikel
1008 Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of proteins inducing apoptosis in the brain of double transgenic mouse model of Alzheimer's disease Dezor, Mateusz
2011
7 4S p. S518-
1 p.
artikel
1009 Expression QTL and regulatory network analysis of bleomycin hydrolase gene Liu, Yan
2011
7 4S p. S199-S200
2 p.
artikel
1010 Extent and impact of missing ADAS-cog items in ADCS clinical trials Schafer, Kimberly
2011
7 4S p. S264-
1 p.
artikel
1011 Extracellular domain of p75NTR attenuates the neurotoxicity of amyloid-beta and proNGF Wang, Yan-Jiang
2011
7 4S p. S475-S476
2 p.
artikel
1012 Extracellular tau levels in cultured cells are influenced by genetic variants associated with dementia Karch, Celeste
2011
7 4S p. S690-S691
2 p.
artikel
1013 Extracts from Bupleurum marginatum inhibit glycogen synthase kinase 3β Kaufmann, Dorothea
2011
7 4S p. S655-S656
2 p.
artikel
1014 Extrapyramidal features and white matter lesions in healthy aging, cognitive impairment and dementia: The PIETÀ study Barbosa, Maira Tonidandel
2011
7 4S p. S156-
1 p.
artikel
1015 Face, scene and object perception in posterior cortical atrophy Shakespeare, Tim
2011
7 4S p. S265-
1 p.
artikel
1016 Facial expressions as predictors of pain for patients with dementia Lin, Li-Chan
2011
7 4S p. S633-S634
2 p.
artikel
1017 Facile synthesis of beta-amyloid by solid-phase peptide synthesis Lee, Jun Seok
2011
7 4S p. e22-
1 p.
artikel
1018 Factors associated with cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology Negash, Selamawit
2011
7 4S p. S324-
1 p.
artikel
1019 Factors associated with cognitive impairment in older adults: A population based survey, south Brazil Dorsi, Eleonora
2011
7 4S p. S370-
1 p.
artikel
1020 Factors that influence survival in Alzheimer's patients Rountree, Susan
2011
7 4S p. S513-
1 p.
artikel
1021 False Reassurance Following Genetic Susceptibility Testing for Alzheimer’s Disease: Evidence from the REVEAL Study Bradbury, Margaret
2011
7 4S p. S179-S180
2 p.
artikel
1022 Familiar functionality in cognitively impaired elderly in a long-term care institution Pavarini, Sofia
2011
7 4S p. S631-
1 p.
artikel
1023 Family functioning and social support for elderly people with cognitive impairments, living in impoverished environments Pavarini, Sofia
2011
7 4S p. S625-S626
2 p.
artikel
1024 Family history of non-Alzheimer's Demeutia memory problems predicts rate of cognitive decline in APOE E4 non-carriers in Alzheimer's disease: The Cache County Dementia Progression Study. Tschanz, JoAnn
2011
7 4S p. S366-
1 p.
artikel
1025 Family involvement in care of Korean and US family members of persons with dementia in long term care Park, Myonghwa
2011
7 4S p. S433-
1 p.
artikel
1026 FDG-PET and amyloid imaging in the dominantly inherited Alzheimer network Klunk, William
2011
7 4S p. S680-
1 p.
artikel
1027 FDG-PET and CSF proteins: Are these Alzheimer's disease biomarkers interchangeable? Yakushev, Igor
2011
7 4S p. S152-
1 p.
artikel
1028 FDG-PET cortical metabolic activity associated with distinct ‘agitation’ behaviors in Alzheimer's disease Sultzer, David
2011
7 4S p. S79-S80
2 p.
artikel
1029 FDG-PET cortical metabolic activity associated with distinct “agitation” behaviors in Alzheimer's disease Sultzer, David
2011
7 4S p. S744-S745
2 p.
artikel
1030 FDG-PET study on dementia of Alzheimer's type of less educated subjects Huang, Yu-Ching
2011
7 4S p. S736-S737
2 p.
artikel
1031 Fewer Paris, parrots peaches: Interpreting cross-cultural semantic fluency deficits in Alzheimer's assessment Khan, Katija
2011
7 4S p. S294-
1 p.
artikel
1032 [18F]-Flutemetamol amyloid PET imaging in patients with normal pressure hydrocephalus Wolk, David
2011
7 4S p. S728-
1 p.
artikel
1033 Field test of caregiver's manual for robot therapy using therapeutic seal robot Wada, Kazuyoshi
2011
7 4S p. S636-S637
2 p.
artikel
1034 Finding new susceptibility genes for Alzheimer's disease: The GERAD consortium Gerrish, Amy
2011
7 4S p. S84-
1 p.
artikel
1035 Findings from a randomized, placebo-control, clinical trial examining the potential cognitive effects of soy isoflavones in patients with Alzheimer's disease Gleason, Carey
2011
7 4S p. e57-e58
nvt p.
artikel
1036 First in man study to image alpha4beta2 cerebral nicotinic acetylcholine receptors (nAChRs) in early Alzheimer's disease (AD) with the new radioligand (-)-[18F]-norchloro-fluoro-homoepibatidine (NCFHEB) and PET Sabri, Osama
2011
7 4S p. S37-
1 p.
artikel
1037 Fit for purpose Clinical validation of a multiplex immunoassay for the measurement of Tau, p-Tau and Abeta 42 Berisha, Flora
2011
7 4S p. S382-
1 p.
artikel
1038 Five-country survey of public experiences, attitudes and beliefs concerning Alzheimer's disease and the value of a diagnosis Blendon, Robert
2011
7 4S p. e50-
1 p.
artikel
1039 F-18 labeled Bis-dialkylamino-curcuminoid as a potential amyloid-beta imaging agent Ran, Chongzhao
2011
7 4S p. S308-
1 p.
artikel
1040 Florbetapir PET correlates with cognitive decline, PIB PET and CSF markers in the ADNI database Pontecorvo, Michael J
2011
7 4S p. S697-
1 p.
artikel
1041 Fluorescence imaging of cdk5, GSK-3b, MARK, and Fyn kinase activities in solution and in cells via novel encodable sensors Zondlo, Neal
2011
7 4S p. e25-e26
nvt p.
artikel
1042 Fluorescent dyes detect Aβ- and Tau-pathology post mortem and in vivo Schmidt, Boris
2011
7 4S p. S306-
1 p.
artikel
1043 Fluorinated Amyloid Ligands for PET Herholz, Karl
2011
7 4S p. S1-
1 p.
artikel
1044 fMRI Context-dependent connectivity in Alzheimer's disease McLaren, Donald
2011
7 4S p. S740-
1 p.
artikel
1045 Follow-up study of PiB negative dementia Ataka, Suzuka
2011
7 4S p. S730-
1 p.
artikel
1046 Formal caregivers in assisted residences of the province of Alicante, Spain: Analysis of their needs and expectations of formation in dementias Toribio-Díaz, Elena
2011
7 4S p. S434-
1 p.
artikel
1047 Formal education after 60 years improves cognitive performance da Silva, Eduardo Marques
2011
7 4S p. S503-
1 p.
artikel
1048 Formation of nicastrin and APH1 subcomplex is necessary for recruitment of substrate CTFβ Xu, Xuemin
2011
7 4S p. e25-
1 p.
artikel
1049 Former alcoholics show deficits in memory Junior, Emilio Herrera
2011
7 4S p. S638-S639
2 p.
artikel
1050 Fractal differences in MRI time series between Alzheimer's disease patients and controls Wink, Alle Meije
2011
7 4S p. S229-
1 p.
artikel
1051 Frailty and other predictors of the quality of life for people with Alzheimer's disease Mhaolain, Aine Ni
2011
7 4S p. e68-
1 p.
artikel
1052 Frailty criteria and MMSE performance are related: total score and subdomain analyses using data from the FIBRA multicenter study in Brazil Mônica, Yassuda
2011
7 4S p. S503-S504
2 p.
artikel
1053 Free and cued selective reminding in mild cognitive impairment and Alzheimer's disease Lemos, Raquel
2011
7 4S p. S252-
1 p.
artikel
1054 Free and cued selective reminding test: A validity study in subjects attending memory clinics Pomati, Simone
2011
7 4S p. e17-
1 p.
artikel
1055 FreeSurfer in regional analysis of beta-amyloid deposition with [11C]PIB positron emission tomography Su, Yi
2011
7 4S p. S227-
1 p.
artikel
1056 Frequency of mixed brain pathologies in African-Americans and Whites with dementia Barnes, Lisa
2011
7 4S p. S592-
1 p.
artikel
1057 From in silico to in vitro to in vivo: - Novel approach in Alzheimer's disease drug discovery Wang, Jun
2011
7 4S p. S476-
1 p.
artikel
1058 From tau biology to tauopathy: Toward new therapeutic strategies Buee, Luc
2011
7 4S p. S673-S674
2 p.
artikel
1059 Frontal and parietal oxygenation during two diagnostic tests for Alzheimer's disease Müller, Laura
2011
7 4S p. S721-
1 p.
artikel
1060 Frontal white matter hyperintensities correlate with depressive symptoms and functionality in mild Alzheimer's patients Bilgic, Basar
2011
7 4S p. S731-
1 p.
artikel
1061 Frontolimbic brain regions associated with agitation and aggression symptoms in MCI and AD over a 2-year period Trzepacz, Paula
2011
7 4S p. e75-
1 p.
artikel
1062 Frontotemporal lobal involvement in advanced amyotrophic lateral sclerosis-CT imaging study Watanabe, Chigusa
2011
7 4S p. e42-
1 p.
artikel
1063 Frontotemporal lobar degeneration: diagnosis and epidemiology in a Colombian memory clinic through thirteen years (1997-2010) de Sanchez, Carolina Ruiz
2011
7 4S p. S372-
1 p.
artikel
1064 18F-SNUBH-NM-333 as a potential probe for PET imaging of amyloid plaques Kim, Sang Eun
2011
7 4S p. S719-S720
2 p.
artikel
1065 Functional analysis of Alzheimer’s diseaseupregulated genes Mitchelmore, Cathy
2011
7 4S p. S115-
1 p.
artikel
1066 Functional analysis of the MAPT promoter haplotypes Caffrey, Tara
2011
7 4S p. S201-
1 p.
artikel
1067 Functional brain networks integrity in patients with Alzheimer's disease and mild cognitive impairment Pievani, Michela
2011
7 4S p. S218-S219
2 p.
artikel
1068 Functional cDNA screening identifies BACE-2 as a principal beta-amyloid degrading protease Abdul-Hay, Samer
2011
7 4S p. S105-
1 p.
artikel
1069 Functional connectivity in dementia with lewy bodies and Alzheimer's Disease: A Resting BOLD Study Kenny, Eva
2011
7 4S p. S340-
1 p.
artikel
1070 Functional connectivity in dementia with Lewy bodies and Alzheimer's disease: A resting BOLD study Kenny, Eva
2011
7 4S p. S3-
1 p.
artikel
1071 Functional connectivity in the episodic memory network Oedekoven, Christiane
2011
7 4S p. e36-
1 p.
artikel
1072 Functional correlations of intracellular Aβ peptide in transgenic mouse models Delatour, Benoît
2011
7 4S p. S491-
1 p.
artikel
1073 Functional Impairment in Preclinical Alzheimer’s Disease Pérès, Karine
2011
7 4S p. S281-
1 p.
artikel
1074 Functional independence and tests of cognitive assessment in patients with Alzheimer's disease Oliveira, Fabricio
2011
7 4S p. S258-S259
2 p.
artikel
1075 Functional neural mechanisms underlying executive functioning in mild cognitive impairment and Alzheimer's disease: An EEG coherence study Johns, Erin
2011
7 4S p. S737-
1 p.
artikel
1076 Gait patterns in the elderly and their association with cognition Verlinden, Vincentius
2011
7 4S p. S693-
1 p.
artikel
1077 Gamma- secretase and synaptic plasticity Yueming, Li
2011
7 4S p. S490-
1 p.
artikel
1078 Gamma-secretase modulator resistance can be overcome for many pathogenic presenilin mutants by second-generation compounds Steiner, Harald
2011
7 4S p. S105-S106
2 p.
artikel
1079 Gamma—secretase modulators do not show a potency shift in high expressing model systems Bronk, Brian
2011
7 4S p. S119-S120
2 p.
artikel
1080 Gender differences in cognitive benefits of intranasal insulin Claxton, Amy
2011
7 4S p. S778-S779
2 p.
artikel
1081 Gender modifying-effect between APOE and cognitive decline in Alzheimer's disease: The Cache County dementia progression study Tripodis, Yorghos
2011
7 4S p. S601-S602
2 p.
artikel
1082 Gene and cell therapy approaches for prion diseases Gabelle, Audrey
2011
7 4S p. S653-
1 p.
artikel
1083 Gene, exercise and memory study (GEMS): A randomized controlled clinical trial to evaluate the effects of standardized aerobic exercise on neurocognition and neurodegeneration in african americans with mild Alzheimer's disease Obisesan, Thomas
2011
7 4S p. S615-S616
2 p.
artikel
1084 Gene expression profiling in postmortem brains classified by Braak neurofibrillary tangle staging Hatsuta, Hiroyuki
2011
7 4S p. S154-S155
2 p.
artikel
1085 Gene expression profiling of choroid plexus in Alzheimer's disease reveals important implications of CSF dynamics Stopa, Edward
2011
7 4S p. S707-
1 p.
artikel
1086 General anesthetics influence autophagy and neurodegeneration through actions on the inositol 1,4,5-Trisphosphate receptor calcium channel Peng, Yi
2011
7 4S p. S573-
1 p.
artikel
1087 Generation and characterization of a CALHM1 knockout mouse model: Relevance for Alzheimer's disease Vingtdeux, Valerie
2011
7 4S p. S506-
1 p.
artikel
1088 Gene regulation by gamma-secretase analyzed by microarray Restituito, Sophie
2011
7 4S p. S125-
1 p.
artikel
1089 Genes Found by GWAS in Alzheimer’s Disease: Comparing VPS10-Containing Receptors with BIN1 and CALM1 St. George Hyslop, Peter
2011
7 4S p. S283-
1 p.
artikel
1090 Gene therapy utilizing growth factors Tuszynski, Mark
2011
7 4S p. S677-
1 p.
artikel
1091 Genetic and environmental factors and mild cognitive impairment in patients with type 2 diabetes Qi, Xiuying
2011
7 4S p. S371-
1 p.
artikel
1092 Genetic Association Between CALHM1, 2 and 3 Polymorphisms and Alzheimer’s Disease in a Japanese Population Shibata, Nobuto
2011
7 4S p. S195-
1 p.
artikel
1093 Genetic dissection of APP gene family for synaptic function, learning and memory Mueller, Ulrike
2011
7 4S p. S99-
1 p.
artikel
1094 Genetic epidemiological studies of MRI pathology: the CHARGE consortium DeCarli, Charles
2011
7 4S p. S486-
1 p.
artikel
1095 Genetic factors associated with the rate of cognitive decline in Alzheimer's disease Sherva, Richard
2011
7 4S p. S496-
1 p.
artikel
1096 Genetic knockout of estrogen receptor-ïβ¢ contributes to Alzheimer's disease pathogenesis by impairing mitochondrial function in females Long, Jiangang
2011
7 4S p. S575-
1 p.
artikel
1097 Genetic predictors of progression of cognitive impairment in Two large Canadian cohorts: CSHA and ACCORD Hsiung, Ging-Yuek
2011
7 4S p. S496-
1 p.
artikel
1098 Genetic risk and cognitive performance in the Wisconsin registry for Alzheimer's prevention (WRAP) Sager, Mark
2011
7 4S p. S263-
1 p.
artikel
1099 Genetic Risk Factors for AD Biomarkers Elias-Sonnenschein, Lyzel
2011
7 4S p. S184-
1 p.
artikel
1100 Genetic Risk Factors for Depression in Alzheimer’s Disease Patients Arlt, Sönke
2011
7 4S p. S177-
1 p.
artikel
1101 Genetics of early-onset Alzheimer disease in France Wallon, David
2011
7 4S p. S198-
1 p.
artikel
1102 Genetic studies of Alzheimer's disease Seshadri, Sudha
2011
7 4S p. S83-
1 p.
artikel
1103 Genetic Variability in Tau Dephosphorylation Pathway and Alzheimer’s Disease Risk Vázquez-Higuera, Jose Luis
2011
7 4S p. S197-
1 p.
artikel
1104 Genetic Variants Influencing Human Longevity from Late-Onset Alzheimer’s Disease (LOAD) Genome-Wide Association Studies (GWAS) Shi, Hui
2011
7 4S p. S195-
1 p.
artikel
1105 Genome-Wide Analysis of Large Rare Copy Number Variations in Alzheimer Disease Among Caribbean Hispanics Rogaeva, Ekaterina
2011
7 4S p. S193-S194
2 p.
artikel
1106 Genome-Wide Association Analyses Using Cerebrospinal Fluid Tau and Phospho-Tau Levels As An Endophenotype for Alzheimer’s Disease Cruchaga, Carlos
2011
7 4S p. S182-
1 p.
artikel
1107 Genome-Wide Association Analysis Identifies Novel Loci Associated with the Onset Age Among Cases with Late-Onset Alzheimer’s Disease Martin, Eden
2011
7 4S p. S189-S190
2 p.
artikel
1108 Genome-wide association analysis using cerebrospinal fluid Abeta42 levels as an endophenotype for Alzheimer's disease Kauwe, John
2011
7 4S p. e69-e70
nvt p.
artikel
1109 Genome-wide association of longitudinal volumetric mri measurements in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study Sun, Jia
2011
7 4S p. S53-
1 p.
artikel
1110 Genome-wide association of longitudinal volumetric MRI measurements in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study Sun, Jia
2011
7 4S p. S199-
1 p.
artikel
1111 Genome-Wide association scan replication for biomarker endophenotypes of Alzheimer's disease Wilhelmsen, Kirk
2011
7 4S p. S335-S336
2 p.
artikel
1112 Genome-wide association studies of CSF biomarkers Kauwe, John
2011
7 4S p. S85-
1 p.
artikel
1113 Genome-wide association studies of hippocampal volume: The CHARGE consortium Bis, Joshua
2011
7 4S p. S495-S496
2 p.
artikel
1114 Genome-wide association studies: The EADI consortium Lambert, Jean-Charles
2011
7 4S p. S84-S85
2 p.
artikel
1115 Genome-wide association studies using prospective cohorts: The CHARGE consortium DeStefano, Anita
2011
7 4S p. S84-
1 p.
artikel
1116 Genome-Wide Association Study for Alzheimer’s Disease with Psychotic Symptoms Hollingworth, Paul
2011
7 4S p. S186-
1 p.
artikel
1117 Genome-Wide Association Study of Brain Gene Expression Levels (eGWAS) Ertekin-Taner, Nilufer
2011
7 4S p. S184-
1 p.
artikel
1118 Genome-Wide Association Study of Executive Function Ibrahim-Verbaas, Carla
2011
7 4S p. S186-S187
2 p.
artikel
1119 Genome-Wide Association Study of Late-Onset Alzheimer Disease Identifies Disease-Associated Variants in MS4A4/MS4A6E, CD2AP, CD33, and EPHA1 Naj, Adam
2011
7 4S p. S191-
1 p.
artikel
1120 Genome-wide association study of memory performance Debette, Stéphanie
2011
7 4S p. S93-
1 p.
artikel
1121 Genome-wide association study of white matter lesions in older individuals Assareh, Arezoo
2011
7 4S p. e27-
1 p.
artikel
1122 Genome-Wide Scan Suggested Novel Alzheimer’s Disease Susceptibility Genes by Factoring Influence of APOE Jun, Gyungah
2011
7 4S p. S187-
1 p.
artikel
1123 Genome-wide study for Alzheimer’s disease in the Amish Cummings, Anna
2011
7 4S p. S92-
1 p.
artikel
1124 Geographic variation in mortality from dementia in the United States in 1999-2006 Obisesan, Thomas
2011
7 4S p. S599-
1 p.
artikel
1125 Glial cell line-derived neurotrophic factor in lithium-treated patients with early Alzheimer's disease Leyhe, Thomas
2011
7 4S p. S784-
1 p.
artikel
1126 Glial glutamate transporter EAAT2 as a potential therapeutic target for Alzheimer's disease Kong, Qiongman
2011
7 4S p. S657-
1 p.
artikel
1127 Global cognitive performance and motor control in a cohort of oldest-old: the PIETÀ Study Carvalho, Viviane
2011
7 4S p. S240-
1 p.
artikel
1128 Global economic cost of dementia Wortmann, Marc
2011
7 4S p. S633-
1 p.
artikel
1129 Glucose-dependent insulinotropic peptide mitigates amyloid β-induced neurotoxicity independently of anti-inflammatory mechanisms Figueiredo, Claudia
2011
7 4S p. S652-S653
2 p.
artikel
1130 Glutaminyl cyclase activity is decreased in Alzheimer's cerebrospinal fluid Gunn, Adam
2011
7 4S p. S574-
1 p.
artikel
1131 Glutaminyl cyclases: enzyme targets to treat Alzheimer's disease and neuroinflammation Demuth, Hans
2011
7 4S p. S403-
1 p.
artikel
1132 Glycemic control interacts with inflammation to affect cognition in diabetic elderly Beeri, Michal Schnaider
2011
7 4S p. e26-
1 p.
artikel
1133 Glycogen Syinthase Kinase-3β Activity in Elderly Patients with Bipolar Disorder Ladeira, Rodolfo
2011
7 4S p. S321-
1 p.
artikel
1134 Glycogen synthase kinase-3beta regulates tyrosine-307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src Liu, Gong-Ping
2011
7 4S p. S412-
1 p.
artikel
1135 Glycogen synthase kinase 3 inhibitors promote adult hippocampal neurogenesis Morales-Garcia, Jose A.
2011
7 4S p. S662-S663
2 p.
artikel
1136 Goal-oriented cognitive rehabilitation of memory in early-stage Alzheimer's disease: Single-blind randomized controlled trial of clinical efficacy Claire, Linda
2011
7 4S p. S493-
1 p.
artikel
1137 Going earlier: Using imaging to power studies for clinical disease ‘prevention’ Schott, Jonathan
2011
7 4S p. S806-
1 p.
artikel
1138 golgi fragmentation Jiang, Qian
2011
7 4S p. S406-
1 p.
artikel
1139 GPR3 modulation of the Gamma-secretase complex and Abeta generation in Alzheimer's disease Thathiah, Amantha
2011
7 4S p. S105-
1 p.
artikel
1140 Grading the Credibility of Genetic Associations in Alzheimer’s Disease Using the Interim Venice Criteria Broer, Linda
2011
7 4S p. S180-
1 p.
artikel
1141 Greater impact of white matter hyperintensities on cognition in aPOE carriers Baxter, Leslie
2011
7 4S p. S231-
1 p.
artikel
1142 Greater rate of atrophy in elderly with high versus low Aβ deposition Chetelat, Gaël
2011
7 4S p. S208-
1 p.
artikel
1143 Greater rate of atrophy in elderly with high versus low Aβ deposition Chételat, Gaël
2011
7 4S p. S22-
1 p.
artikel
1144 Grey and white matter correlates of disinhibition in behavioural variant frontotemporal dementia and Alzheimer's disease Hornberger, Michael
2011
7 4S p. S736-
1 p.
artikel
1145 Group CBT focused on Dysfunctional Thoughts about Caregiving (DTC) in Alzheimer's disease caregivers: Interaction between DTC, psychological and cognitive flexibility Topçu, Bahar
2011
7 4S p. S428-
1 p.
artikel
1146 Growth arrest-specific 1 (Gas1) binds to and controls the maturation and processing of APP Chapuis, Julien
2011
7 4S p. S384-
1 p.
artikel
1147 GSK-3 activation retards the axonal transport Liu, Dan
2011
7 4S p. S587-
1 p.
artikel
1148 GSK-3 inhibitors in Alzheimer's disease Lo Monte, Fabio
2011
7 4S p. S483-
1 p.
artikel
1149 GSK3, tau, neurogenesis and memory loss in Alzheimer's disease Avila, Jesus
2011
7 4S p. S809-
1 p.
artikel
1150 Hallucinations and Alzheimer's disease, correlations to brain volume and metabolism: A study of the ADNI cohort Blanc, Frederic
2011
7 4S p. S731-
1 p.
artikel
1151 Head circumference, atrophy and cognition: implications for brain reserve in Alzheimer's disease Kurz, Alexander
2011
7 4S p. S486-
1 p.
artikel
1152 Heading disorientation in young-onset Alzheimer's disease patients Pai, Ming-Chyi
2011
7 4S p. S260-
1 p.
artikel
1153 Health care of people with dementia in Germany in 2030 - a multidisciplinary scenario approach (Sce-Dem) Vollmar, Horst
2011
7 4S p. S447-S448
2 p.
artikel
1154 Health care utilization in frontotemporal lobar degeneration Diehl-Schmid, Janine
2011
7 4S p. S634-
1 p.
artikel
1155 Health trajectories in caregivers of dementia patients Perkins, Martinique
2011
7 4S p. S433-S434
2 p.
artikel
1156 Healthy older adults in the AIBL cohort at risk for cognitive decline Szoeke, Cassandra
2011
7 4S p. e6-e7
nvt p.
artikel
1157 Hearing impairment and cognitive screening: A pitfall often unrecognized Decker-Maruska, Mechthild
2011
7 4S p. S498-S499
2 p.
artikel
1158 Hearing impairment and dementia: A different story in basic and further nursing education Decker-Maruska, Mechthild
2011
7 4S p. S634-
1 p.
artikel
1159 Heat shock proteins alter in vivo abeta amyloid peptide aggregation Maddelein, Marie-Lise
2011
7 4S p. S389-S390
2 p.
artikel
1160 Hematopoietic stem cell-derived monocytic cells are capable of clearing amyloid-beta in Alzheimer's disease mouse model Savchenko, Ekaterina
2011
7 4S p. S664-
1 p.
artikel
1161 Hemodynamic correlates of vascular risk factors in patients with Alzheimer's disease Yamazaki, Takashi
2011
7 4S p. S747-
1 p.
artikel
1162 Heritability of neuropsychologically defined MCI in midlife: A twin study of men in their 50s Kremen, William
2011
7 4S p. S680-S681
2 p.
artikel
1163 Heterogeneity of atrophy patterns in mild cognitive impairment and relationship to CSF biomarkers of Alzheimer's pathology Lehmann, Manja
2011
7 4S p. S29-S30
2 p.
artikel
1164 Heterogeneity of atrophy patterns in mild cognitive impairment and relationship to CSF biomarkers of Alzheimer's pathology Lehmann, Manja
2011
7 4S p. S107-
1 p.
artikel
1165 High CSF tau predicts rapid decline to Alzheimer's type dementia in MCI subjects with abnormal CSF Aß1-42 van Rossum, Ineke
2011
7 4S p. S548-
1 p.
artikel
1166 Higher expressions of macromolecular forms and C-terminal domain of plasma fibronectin more frequently associated with Alzheimer's disease Leszek, Jerzy
2011
7 4S p. e14-
1 p.
artikel
1167 Higher rate of beta-amyloid accumulation in precuneus in cognitively normal APOE E4 carriers compared to non-carriers Vlassenko, Andrei
2011
7 4S p. S697-S698
2 p.
artikel
1168 High-intensity physical activity modulates diet-induced changes in CSF Aβ42 Skinner, Jeannine
2011
7 4S p. S666-
1 p.
artikel
1169 High-resolution amyloid plaque imaging using differential phase contrast x-ray tomography Cacquevel, Matthias
2011
7 4S p. S55-S56
2 p.
artikel
1170 High-resolution 3-dimensional reconstruction reveals early intra-synaptic amyloid fibrils in Alzheimer's transgenic mice Gouras, Gunnar
2011
7 4S p. e46-e47
nvt p.
artikel
1171 High-resolution multi-elemental metallomic mapping of the brain in the tg2576 transgenic mouse model of Alzheimer's disease Moncaster, Juliet
2011
7 4S p. S391-S392
2 p.
artikel
1172 High-resolution multi-elemental metallomic mapping of the human eye in Alzheimer's disease and normal aging Casey, Noel
2011
7 4S p. S386-
1 p.
artikel
1173 High-throughput and accurate segmentation of lateral ventricles using combined single atlas propagation and tissue classification: Application to ADNI and IBSR data Belaroussi, Boubakeur
2011
7 4S p. S204-
1 p.
artikel
1174 High-throughput and accurate segmentation of lateral ventricles using combined single atlas propagation and tissue classification: Application to ADNI and IBSR data Belaroussi, Boubakeur
2011
7 4S p. S20-
1 p.
artikel
1175 Hippocampal decline in Alzheimer's disease affects ventromedial prefrontal cortex functioning Meulenbroek, Olga
2011
7 4S p. S75-
1 p.
artikel
1176 Hippocampal metabolism deficit in elderly with mild cognitive impairment Lakatos, Anita
2011
7 4S p. S321-S322
2 p.
artikel
1177 Hippocampal microstructure and memory performance in Alzheimer's disease: A 7-Tesla MRI study Kerchner, Geoffrey
2011
7 4S p. S719-
1 p.
artikel
1178 Hippocampal microstructure and memory performance in Alzheimer's disease: A 7-Tesla MRI study Kerchner, Geoffrey
2011
7 4S p. S60-S61
2 p.
artikel
1179 Hippocampal neurotrophic signaling and endosomal-lysosomal pathway dysfunction in mild cognitive impairment Mufson, Elliott
2011
7 4S p. S685-
1 p.
artikel
1180 Hippocampal resting-state connectivity lateralize memory function in aMCI brain networks Schoemaker, Dorothee
2011
7 4S p. S78-S79
2 p.
artikel
1181 Hippocampal subfields at 7T MRI: In vivo volumetric assessment Wisse, Laura
2011
7 4S p. e42-
1 p.
artikel
1182 Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? Marchetti, Cristina
2011
7 4S p. S523-
1 p.
artikel
1183 Hippocampal volume in neuropsychologically-defined MCI in men in their 50s Jak, Amy
2011
7 4S p. S538-S539
2 p.
artikel
1184 Hippocampal volume in neuropsychologically defined MCI in men in their 50s Jak, Amy
2011
7 4S p. S27-
1 p.
artikel
1185 Hippocampal volumes are associated with cognitive performance in recently menopausal APOE ϵ4 carriers Kantarci, Kejal
2011
7 4S p. S611-S612
2 p.
artikel
1186 Histaminergic H3 receptors in subcortical ischemic vascular dementia Sheng, Yuan
2011
7 4S p. S763-
1 p.
artikel
1187 Histological localization of amyloid-β oligomers in the human brain during the course of Alzheimer's disease Panchal, Maï
2011
7 4S p. S393-S394
2 p.
artikel
1188 Histopathological analysis of progranulin knockout mice Arai, Tetsuaki
2011
7 4S p. S113-
1 p.
artikel
1189 1H magnetic resonance spectroscopy findings of normal individual and Alzheimer's disease patients Kin-Wah Liu,
2011
7 4S p. S81-S82
2 p.
artikel
1190 Home Care Program for people with Alzheimer's disease and their caregivers Margioti, Eleni
2011
7 4S p. S437-S438
2 p.
artikel
1191 Hormetic effect of amyloid-beta peptide on synaptic plasticity and memory Puzzo, Daniela
2011
7 4S p. S116-
1 p.
artikel
1192 How do caregiver's features influence the sense of burden? Silvestre, Ana
2011
7 4S p. S431-
1 p.
artikel
1193 How does diabetes affect plaque and tangle pathology in Alzheimer's Disease? Obradov, Aleksandra
2011
7 4S p. S706-
1 p.
artikel
1194 How older adults with Alzheimer's disease allocate gaze during visual search Pino, Maribel
2011
7 4S p. S261-
1 p.
artikel
1195 How prevalent are vascular lesions among early-onset Alzheimer's patients? Bombois, Stephanie
2011
7 4S p. S130-S131
2 p.
artikel
1196 How will amyloid imaging really be used inside and outside clinical trials? Jagust, William
2011
7 4S p. S806-
1 p.
artikel
1197 Hsp90 and toxic proteins in neurodegenerative disease Bajic, Vladan
2011
7 4S p. S711-S712
2 p.
artikel
1198 HTA-SADD a definative multicentre placebo controlled RCT of the clinical effectiveness of sertraline and mirtazapine for the treatment of depression in dementia Banerjee, Sube
2011
7 4S p. S299-
1 p.
artikel
1199 5-HT4 receptor agonist, SUVN-1004028, for the treatment of Alzheimer's disease Ahmad, Ishtiyaque
2011
7 4S p. S669-
1 p.
artikel
1200 Human Genomic Transgenes of Presenilin-1 Help Elucidate Novel Mechanisms of Alzheimer’s Disease Pathology Ahmadi, Sara
2011
7 4S p. S177-
1 p.
artikel
1201 Human prion diseases in Japan: analysis of 1,552 patients in a prospective 11-year surveillance Yamada, Masahito
2011
7 4S p. S687-
1 p.
artikel
1202 Human stem cell-derived neurones as a model to study tau function and dysfunction Iovino, Mariangela
2011
7 4S p. S555-
1 p.
artikel
1203 Hyperactivation of PI3-kinase-Akt signaling: a central molecular link between early Amuloid beta and tau pathogenesis in Alzheimer's disease O' Neill, Cora
2011
7 4S p. S583-S584
2 p.
artikel
1204 Hyperglycemia increases amyloid accumulation and exacerbates cerebrovascular pathology in Alzheimer's disease model animals Asuni, Ayodeji
2011
7 4S p. S515-
1 p.
artikel
1205 Hyperhomocysteinemia impairs spatial memory and inhibits long-term potentiation (LTP) by modulation synapse-associated proteins in rat brain Jiang, Xia
2011
7 4S p. S754-
1 p.
artikel
1206 Hyperphosphorylation along the C-terminal of tau protein is associated with PHF assembly resulting from truncation at Glu-391, in AlzheimerÂś disease Luna-Muñoz, José
2011
7 4S p. S705-
1 p.
artikel
1207 Hypertension and alzheimer's disease: Further steps towards prevention strategy Dufouil, Carole
2011
7 4S p. S89-
1 p.
artikel
1208 Hypertension, antihypertensive treatments and dementia in the oldest old: The Monzino 80-plus Study Lucca, Ugo
2011
7 4S p. S356-
1 p.
artikel
1209 Hypertension-related cognitive decline in an Alzheimer's disease center population Williams, Schantel
2011
7 4S p. S269-
1 p.
artikel
1210 Hypertension triggers vascular-related Alzheimer's by activation of RAGE Carnevale, Daniela
2011
7 4S p. e4-e5
nvt p.
artikel
1211 Hypothyreosis as the risk-factor of dementia in elderly Lonbjanidze, Nino
2011
7 4S p. S758-
1 p.
artikel
1212 Identification and validation of a blood-based transcriptomic signature (AclarusDx) in the diagnosis of Alzheimer's disease Einstein, Rich
2011
7 4S p. e13-
1 p.
artikel
1213 Identification of a gene which controls Abeta accumulation using APP Tg mice with mixed genetic Background Splicing variant specific effect of Kinesin Light Chain 1 (Klc1) Yokokoji, Mikiko
2011
7 4S p. S104-
1 p.
artikel
1214 Identification of Alzheimer’s Disease Haplotype that Predicts Efficiency of SORL1/SORLA Expression in the Brain Caglayan, Safak
2011
7 4S p. S180-
1 p.
artikel
1215 Identification of An Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene Schnetz-Boutaud, Nathalie
2011
7 4S p. S194-S195
2 p.
artikel
1216 Identification of An Independent APP Locus Duplication in a Spanish Family with Early-Onset Alzheimer’s Disease and Severe Cerebral Amyloid Angiopathy Antonell, Anna
2011
7 4S p. S194-
1 p.
artikel
1217 identification of enzymes involved in n-terminal truncation and modification of amyloid peptide Caillava, Celine
2011
7 4S p. S382-
1 p.
artikel
1218 Identification of Exebryl-1® and other novel small molecules as tau protein aggregation inhibitors Hu, Qubai
2011
7 4S p. S481-
1 p.
artikel
1219 Identification of first and second generation ATase1 and ATase2 inhibitors that reduce BACE1 levels and Aβ generation Ding, Yun
2011
7 4S p. e63-
1 p.
artikel
1220 Identification of Gene-Gene Interactions in Alzheimer Disease Using Co-Operative Game Theory Vardarajan, Badri Narayan
2011
7 4S p. S197-
1 p.
artikel
1221 Identification of heterogeneity in the cognitive functioning of AIBL healthy controls Ellis, Kathryn
2011
7 4S p. S272-
1 p.
artikel
1222 Identification of MyD88 as canonical regulator of NF-kB, and possible improvements for anti-inflammatory therapies Mitrasinovic, Olivera
2011
7 4S p. S478-
1 p.
artikel
1223 Identification of novel components of neurofibrillary tangles in Alzheimer brains Takahashi, Hiroshi
2011
7 4S p. S708-
1 p.
artikel
1224 Identification of novel selective and drug-like antagonist of H3 Receptor – O2h-1008 Shirsath, Vikas
2011
7 4S p. S801-
1 p.
artikel
1225 Identification of proteins associated in three different populations of NTFS by mass spectrometry in cases of patients with AD Minjarez, Benito
2011
7 4S p. S323-
1 p.
artikel
1226 Identification of proteins associated to NTFs immunostained with three anti-Tau antibodies in patients with Alzheimer's Disease by tandem mass spectrometry Minjarez, Benito
2011
7 4S p. S323-
1 p.
artikel
1227 Identification of secretase-independent beta-amyloid-lowering agents via ultra-high throughput compound screening Leissring, Malcolm
2011
7 4S p. S464-
1 p.
artikel
1228 Identification of Spline Functions and Cohort Differences in Psychometric Measures of the Long Beach Longitudinal Study Kennison, Robert F.
2011
7 4S p. S173-
1 p.
artikel
1229 Identification of the tau interactome in mouse brain Moechars, Dieder
2011
7 4S p. S115-
1 p.
artikel
1230 Identifying endogenous anti-amyloid compounds Weaver, Donald
2011
7 4S p. S476-
1 p.
artikel
1231 Image processing pipeline for deformable registration Teverovsky, Leonid
2011
7 4S p. S66-
1 p.
artikel
1232 Imaging Amyloid and Cerebrovascular Disease in Aging Marchant, Natalie
2011
7 4S p. S284-S285
2 p.
artikel
1233 Imaging amyloid plaque deposition with [18F]-AV-45 in living APP/PS1-21 mice Poisnel, Géraldine
2011
7 4S p. e15-
1 p.
artikel
1234 Imaging and cerebrospinal fluid biomarker results of a phase II dose-ranging study of ELND005 (Scyllo-inositol) in mild-to-moderate Alzheimer's disease Porsteinsson, Anton
2011
7 4S p. S695-
1 p.
artikel
1235 Imaging brain amyloid in non-demented young adults with Down syndrome using PiB-PET Cohen, Ann
2011
7 4S p. e35-
1 p.
artikel
1236 Imaging brain fibrillar β-amyloid in adults with Down syndrome (DS) using [11C] PiB-PET: acceptability, feasibility and preliminary results Jean-Claude Baron,
2011
7 4S p. S70-
1 p.
artikel
1237 Imaging dementia: The cognitive correlates of functional status Royall, Donald
2011
7 4S p. S743-S744
2 p.
artikel
1238 Imaging for MCI/Alzheimer's trials: How to do it? Barkhof, Frederik
2011
7 4S p. S805-S806
2 p.
artikel
1239 Imaging of cholinergic forebrain degeneration across the aging-MCI-Alzheimer's continuum Grothe, Michel
2011
7 4S p. S26-
1 p.
artikel
1240 Imaging Outcomes for Clinical Trials In Different Stages of Alzheimer's Disease Vernooij, Meike
2011
7 4S p. S806-
1 p.
artikel
1241 Immune and injury response in neurodegeneration Wyss-Coray, Tony
2011
7 4S p. S86-
1 p.
artikel
1242 Immunization with a pseudo-phosphorylated tau epitope clears tau pathology in a mouse model Krishnamurthy, Pavan
2011
7 4S p. S481-S482
2 p.
artikel
1243 Immunization with short Amyloid β immunogens in vivo restores low-response bone-marrow derived dendritic cells in 8-week-old APP/PS1 transgenic mice Shi, Jian-Quan
2011
7 4S p. e63-e64
nvt p.
artikel
1244 Immunomodulation of app processing via the endosomal pathway Solomon, Beka
2011
7 4S p. S479-
1 p.
artikel
1245 Immunotherapy in a hypercholesterolemic rabbit model of Alzheimer's disease Woodruff-Pak, Diana S.
2011
7 4S p. S127-
1 p.
artikel
1246 Impact of amyloid deposition on neural and cognitive function in a large lifespan sample of healthy adults Park, Denise
2011
7 4S p. S1-S2
2 p.
artikel
1247 Impact of an interdisciplinary team on medication management in dementia patients Blumenthal, Jacob
2011
7 4S p. S445-S446
2 p.
artikel
1248 Impact of APOE Genotype Disclosure on Exercise and Mental Activities Klopfenstein, Erin
2011
7 4S p. S188-
1 p.
artikel
1249 Impact of Butyrylcholinesterase K genotype on glial and proinflammatory markers in CSF of patients with Alzheimer's disease. Darreh-Shori, Taher
2011
7 4S p. S407-
1 p.
artikel
1250 Impact of cardiovascular risk factors over age of Alzheimer's disease onset in patients with low schooling Oliveira, Fabricio
2011
7 4S p. S360-S361
2 p.
artikel
1251 Impact of Dementia Subtype and Disease Staging on Carer Burden in Frontotemporal Dementia Mioshi, Eneida
2011
7 4S p. S291-
1 p.
artikel
1252 Impact of different γ-secretase modulators on Notch-1 Abeta-like peptide (Nβ) formation Wanngren, Johanna
2011
7 4S p. S411-S412
2 p.
artikel
1253 Impact of hormone replacement therapy (HRT) usage on 7-year outcome of older persons with subjective cognitive impairment Reisberg, Barry
2011
7 4S p. S97-
1 p.
artikel
1254 Impact of participation in TimeSlips, a creative group-based storytelling program, on medical student attitudes towards persons with dementia: a mixed methods evaluation George, Daniel
2011
7 4S p. S637-
1 p.
artikel
1255 Impact of prescription drug coverage on use of anti-dementia drugs Fowler, Nicole
2011
7 4S p. S643-
1 p.
artikel
1256 Impact of schooling and cardiovascular risk factors over the rate of progression of Alzheimer's disease Oliveira, Fabricio
2011
7 4S p. S599-S600
2 p.
artikel
1257 Impaired connectivity between functional brain modules reflects cognitive dysfunction in Alzheimer's disease de Haan, Willem
2011
7 4S p. S57-
1 p.
artikel
1258 Impaired insulin signal transduction in neurons may be involved in β-amyloid-induced hyperphosphorylation of tau Tokutake, Takayoshi
2011
7 4S p. S585-
1 p.
artikel
1259 Impaired somatic inhibition in mature granule cells in an animal model of Alzheimer's disease Lien, Cheng-Chang
2011
7 4S p. S587-
1 p.
artikel
1260 Impairment in the maintenance of wakefulness is objectively demonstrated in patients with dementia with lewy bodies Boeve, Bradley
2011
7 4S p. S750-S751
2 p.
artikel
1261 Impairment of the proteasome on frontal cortex in lewy body dementia Vallortigara, Julie
2011
7 4S p. S765-
1 p.
artikel
1262 Importance of cognitivo-emotional dysfunctioning as neuropsychological marker of Alzheimer's disease Heidi, Charvin
2011
7 4S p. S272-
1 p.
artikel
1263 Improved cognitive function following treatment of Alzheimer's patients with repetitive transcranial magnetic stimulation (rTMS) interlaced with cognitive learning treatment Rabey, Jose
2011
7 4S p. S694-S695
2 p.
artikel
1264 Improved quantitative accuracy for early diagnosis of plaque deposition in Alzheimer's disease in transgenic mice Slavine, Nikolai
2011
7 4S p. S308-S309
2 p.
artikel
1265 Improved quantitative accuracy for early diagnosis of plaque deposition in Alzheimer's disease in transgenic mice Slavine, Nikolai
2011
7 4S p. S9-S10
2 p.
artikel
1266 Improvement in behavioral and psychiatric SYMPTOMS (BPSD) in patients with moderate-to-severe Alzheimer's disease by current antidementia treatments Cumbo, Eduardo
2011
7 4S p. S774-
1 p.
artikel
1267 Improvement of cognition by enhancing neurogenesis and neuronal plasticity with a CNTF peptidergic compound Blanchard, Julie
2011
7 4S p. S654-
1 p.
artikel
1268 Improvement of cognitive functions in Alzheimer's disease model mice by genetic and pharmacological inhibition of EP4 receptor Hoshino, Tatsuya
2011
7 4S p. S461-
1 p.
artikel
1269 Improvement of functional status after cognitive activation therapy (CAT) in Alzheimer's disease patients Gollin, Donata
2011
7 4S p. S648-
1 p.
artikel
1270 Improving health care for people with dementia in Germany: The DelpHi study Thyrian, Jochen René
2011
7 4S p. e26-e27
nvt p.
artikel
1271 Improving physician awareness of Alzheimer's disease and enhancing recruitment: The clinician partners program Galvin, James E
2011
7 4S p. S160-
1 p.
artikel
1272 Incidence of Alzheimer's disease and changes of diet Gu, Yian
2011
7 4S p. S624-
1 p.
artikel
1273 Incidence of dementia in the Maracaibo Aging Study Maestre, Gladys
2011
7 4S p. S356-S357
2 p.
artikel
1274 Incidence of diffuse neurofibrillary tangles with calcification (DNTC) in Japan Mochizuki, Akihide
2011
7 4S p. S759-
1 p.
artikel
1275 Incidence, prevalence and predictors of course of mild cognitive impairment: The sydney memory and ageing study Brodaty, Henry
2011
7 4S p. S535-
1 p.
artikel
1276 Incorporation of resveratrol into lipid-core nanocapsules improves its cerebral bioavailability and reduces the Aβ-induced toxicity Frozza, Rudimar L.
2011
7 4S p. S114-
1 p.
artikel
1277 Increased amyloid deposition and parental history of Alzheimer's disease is related to altered default network activity during successful encoding in cognitively normal older adults Vannini, Patrizia
2011
7 4S p. S426-S427
2 p.
artikel
1278 Increased cell death in HeLa and SH-SY5Y cells after knocking down FUS Gladbach, Amadeus
2011
7 4S p. S114-
1 p.
artikel
1279 Increased cerebrospinal fluid levels of Amyloid beta oligomers in patients with Alzheimer's disease Hölttä, Mikko
2011
7 4S p. S318-S319
2 p.
artikel
1280 Increased cortical capillary density in Alzheimer's disease is mediated by frontal lobe neurofibrillary degeneration: The missing link between degenerative and cerebrovascular brain disease Sweat, Haylea
2011
7 4S p. S707-S708
2 p.
artikel
1281 Increased longetivity in patients with DAT through use of CoQ-10 and CPAP Zeitlin, Michel
2011
7 4S p. S804-
1 p.
artikel
1282 Increased phosphorylation of tau and synaptic loss in transgenic mice with presenilin 1 mutation Xifei, Yang
2011
7 4S p. S710-S711
2 p.
artikel
1283 Increase in caudate size with age in carriers of the A431E PSEN1 mutation Ringman, John
2011
7 4S p. S235-
1 p.
artikel
1284 Increase in caudate size with age in carriers of the A431E PSEN1 mutation Ringman, John
2011
7 4S p. S51-
1 p.
artikel
1285 Increasing the validity of the MMSE for the multicultural assessment of Alzheimer's disease Khan, Katija
2011
7 4S p. S249-
1 p.
artikel
1286 Individual differences in cognitive plasticity and variability as predictors of cognitive function in older adults Grand, Jacob
2011
7 4S p. S246-
1 p.
artikel
1287 Individualized Activities Based on Role Identities for People with Dementia Cohen-Mansfield, Jiska
2011
7 4S p. S280-
1 p.
artikel
1288 Indomethacin-loaded nanocapsules reduces Aβ1-42–induced toxicity in organotypic culture Bernardi, Andressa
2011
7 4S p. S113-
1 p.
artikel
1289 Induction of cerebral amyloidosis and memory impairments by blood transfusion in mice models of Alzheimer's disease Morales, Rodrigo
2011
7 4S p. S398-
1 p.
artikel
1290 Induction of TLR9 signaling in 3xTg-AD mice Scholtzova, Henrieta
2011
7 4S p. S665-
1 p.
artikel
1291 Infection of human monocytes, olfactory neuroepithelia, and neuronal cells with Chlamydia pneumoniae alters expression of genes associated with Alzheimer's disease Balin, Brian
2011
7 4S p. S561-S562
2 p.
artikel
1292 Inflammation-induced inhibition of brain-to-blood efflux of amyloid beta is independent of LRP-1 expression and reversed by the antioxidant N-acetylcysteine Erickson, Michelle
2011
7 4S p. S414-
1 p.
artikel
1293 Inflammatory biomarkers and cognitive performance in a community-based sample of Brazilian oldest old Guimarães, Henrique Cerqueira
2011
7 4S p. S137-
1 p.
artikel
1294 Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort Doody, Rachelle
2011
7 4S p. S318-
1 p.
artikel
1295 Inflammatory control of blood-brain barrier amyloid=beta transporters: Differences and similarities when compared to Alzheimer's Disease Erickson, Michelle
2011
7 4S p. S808-
1 p.
artikel
1296 Influence of AD pathology on CSF biomarkers in autopsy-confirmed Dementia With Lewy Bodies patients Slaets, Sylvie
2011
7 4S p. S146-
1 p.
artikel
1297 Influence of aggregation of vascular risk factors on neuropsychological performance and white matter lesions in early Alzheimer's disease Tay, Laura
2011
7 4S p. S267-
1 p.
artikel
1298 Influence of demographic variables in the functionality and cognition in a Brazilian clinical sample Borges, Sheila
2011
7 4S p. S238-
1 p.
artikel
1299 Influence of genetic variation on plasma proteomics in AD, MCI and controls: Pairwise gene-protein analysis in the ADNI-1 cohort Kim, Sungeun
2011
7 4S p. e29-e31
nvt p.
artikel
1300 Influence of the training library composition on a patch-based label fusion method: Application to hippocampus segmentation on the ADNI dataset Coupe, Pierrick
2011
7 4S p. S316-
1 p.
artikel
1301 Influence of the training library composition on a patch-based label fusion method: Application to hippocampus segmentation on the ADNI dataset Coupe, Pierrick
2011
7 4S p. S24-
1 p.
artikel
1302 Influence of White Matter Changes on Instrumental Activities of Daily Living in Mild Cognitive Impairment Yoon, Bora
2011
7 4S p. S169-S170
2 p.
artikel
1303 Inhibition of PARP-1 attenuates tau phosphorylation by regulation of glycogen synthase kinase-3 2011
7 4S p. S154-
1 p.
artikel
1304 Inhibition of PPAR-γ using GW, attenuates transcription factor Nrf-2 expression in PC12 cells Abraki, Shahnaz Babaei
2011
7 4S p. S608-S609
2 p.
artikel
1305 Inhibition of Sin3A/HDAC activity suppresses amyloid β-42 accumulation and toxicity through multiple mechanisms Sekiya, Michiko
2011
7 4S p. S397-S398
2 p.
artikel
1306 Inhibition of TNF-alpha protein synthesis restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation Belarbi, Karim
2011
7 4S p. S649-
1 p.
artikel
1307 In-home daily walking variability: A marker of mild cognitive impairment Dodge, Hiroko
2011
7 4S p. S450-
1 p.
artikel
1308 Injection of Abeta1-42 increases oxidative stress in septal neurons Colom, Luis
2011
7 4S p. e21-
1 p.
artikel
1309 Insomnia and cognitive function in older adults: Results from the Einstein aging study Zimmerman, Molly
2011
7 4S p. S271-
1 p.
artikel
1310 Insulin-degrading enzyme as a potential blood biomarker for Alzheimer's disease Tegg, Michelle
2011
7 4S p. S331-
1 p.
artikel
1311 Insulin like growth factor 1 and late-onset Alzheimer's disease Exel, Eric
2011
7 4S p. S593-S594
2 p.
artikel
1312 Insulin metabolism and the risk of dementia and Alzheimer's disease Breteler, Monique
2011
7 4S p. S486-
1 p.
artikel
1313 Insulin-regulated aminopeptidase in astrocytes: Role in Alzheimer's disease? Yeatman, Holly
2011
7 4S p. S668-
1 p.
artikel
1314 Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case control study Razay, George
2011
7 4S p. S621-
1 p.
artikel
1315 Integrated high-dimensional cortical structural marker for very mild Alzheimer's disease Ming, Jing
2011
7 4S p. S39-S40
2 p.
artikel
1316 Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology Shulman, Joshua
2011
7 4S p. S497-
1 p.
artikel
1317 Integration of cognitive impairments and white matter hyperintensities into a 12-cell diagnostic matrix system: Analysis of 3,966 subjects from the CREDOS study Chung, Chan-Seung
2011
7 4S p. S157-
1 p.
artikel
1318 Interaction between vascular factors and the APOE E4 allele predict rate of progression in Alzheimer's dementia Mielke, Michelle
2011
7 4S p. S598-
1 p.
artikel
1319 Interaction of p24alpha2 with gamma-secretase complex attenuates gamma-cleavage of APP Nishimura, Masaki
2011
7 4S p. S578-
1 p.
artikel
1320 Interactive effects of a sedentary lifestyle and the APOE e4 allele on amyloid deposition Head, Denise
2011
7 4S p. S233-
1 p.
artikel
1321 Interest of CSF p-Tau 181 and Amyloid-beta 1-38 for the diagnosis of frontotemporal dementia Gabelle, Audrey
2011
7 4S p. S335-
1 p.
artikel
1322 Interrater variability of image interpretation for PIB-PET in the diagnosis of Alzheimer's disease Yamane, Tomohiko
2011
7 4S p. S65-
1 p.
artikel
1323 Intracellular Aβ and neuronal death Wirths, Oliver
2011
7 4S p. S491-
1 p.
artikel
1324 Intracellular trafficking and metabolism of APP regulated by novel function of X11L Suzuki, Toshiharu
2011
7 4S p. e24-
1 p.
artikel
1325 Intraneuronal amyloid-beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo Umeda, Tomohiro
2011
7 4S p. S557-
1 p.
artikel
1326 Intravenous immunoglobulin binds to tau, pTau and PrPc in addition to Aβ Schaub, Alexander
2011
7 4S p. S670-
1 p.
artikel
1327 Intravenous immunoglobulin improved cognitive functions in patients with Alzheimer's disease without any changes in PIB retention in the brain Kondo, Masaki
2011
7 4S p. S791-
1 p.
artikel
1328 Investigating Alzheimer's disease in the blood cellular fraction Watt, Andrew
2011
7 4S p. S151-
1 p.
artikel
1329 Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Carter, Stephen F.
2011
7 4S p. S110-
1 p.
artikel
1330 Investigating correlations of cortical atrophy and white matter integrity loss in Alzheimer's subjects using connectivity information Kuceyeski, Amy
2011
7 4S p. S214-
1 p.
artikel
1331 Investigating correlations of cortical atrophy and white matter integrity loss in Alzheimer's subjects using connectivity information Kuceyeski, Amy
2011
7 4S p. S27-S28
2 p.
artikel
1332 Investigating limbic system myelin alteration in Alzheimer's disease Deoni, Sean
2011
7 4S p. S57-S58
2 p.
artikel
1333 Investigating limbic system myelin alteration in Alzheimer's disease Deoni, Sean
2011
7 4S p. S715-
1 p.
artikel
1334 Investigating structural and functional cortical disconnection in Alzheimer's Disease, using diffusion tensor imaging and transcranial magnetic stimulation Wegrzyn, Martin
2011
7 4S p. S746-
1 p.
artikel
1335 Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease Burns, Christine
2011
7 4S p. S44-
1 p.
artikel
1336 Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease Burns, Christine
2011
7 4S p. e8-e9
nvt p.
artikel
1337 Investigating white matter myelin content across the spectrum of Alzheimer's disease Deoni, Sean
2011
7 4S p. S58-
1 p.
artikel
1338 Investigating white matter myelin content across the spectrum of Alzheimer's disease Deoni, Sean
2011
7 4S p. S715-S716
2 p.
artikel
1339 Investigation of alternative binding events between the Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family and BACE1 and its influence on the processing of amyloid precursor protein (APP) von Einem, Bjoern
2011
7 4S p. S400-
1 p.
artikel
1340 Investigation of tau and MARKs interaction by using proximity ligation assay in situ Wu, Di
2011
7 4S p. S336-
1 p.
artikel
1341 Investigation of the central mechanism of action required for antibody mediated phagocytosis of pre-existing plaque and the development of a novel antibody therapeutic for Alzheimer's disease DeMattos, Ronald
2011
7 4S p. e55-
1 p.
artikel
1342 Investigation of the role of tau gene transcriptional regulation in neurodegeneration Anaya, Juan
2011
7 4S p. S552-
1 p.
artikel
1343 In vitro blood-brain barrier models and their use in Alzheimer's disease research Deli, Maria
2011
7 4S p. S807-S808
2 p.
artikel
1344 In-vitro mechanisms of action of naturally occurring autoantibodies against Aβ Gold, Maike
2011
7 4S p. S460-
1 p.
artikel
1345 In vitro study on Pittsburgh Compound-B (PIB) binding to brain amyloid plaques in mouse models of Alzheimer's Disease (AD) Zeng, Zhizhen
2011
7 4S p. S311-
1 p.
artikel
1346 In-vivo detection of age-related cerebral glucose uptake alterations by pet in microcebus murinus primates Daorieux, Ole ne
2011
7 4S p. S306-
1 p.
artikel
1347 Invivo detection of age-related cerebral glucose uptake alterations by PET in microcebus murinus primates Dorieux, Olene
2011
7 4S p. S8-S9
2 p.
artikel
1348 In vivo follow-up of cerebral aging and side effects of anti-amyloid immunotherapies in the mouse lemur primate Joseph-Mathurin, Nelly
2011
7 4S p. S462-S463
2 p.
artikel
1349 In vivo follow-up of cerebral aging and side effects of anti-amyloid immunotherapies in the mouse lemur primate Joseph-Mathurin, Nelly
2011
7 4S p. S44-
1 p.
artikel
1350 In vivo imaging of cholinergic structural degeneration in Alzheimer's disease Teipel, Stefan
2011
7 4S p. S109-
1 p.
artikel
1351 In vivo localization of aging and Alzheimer's disease effects on cortical gray matter in normal elderly and patients with mild cognitive impairment Prestia, Annapaola
2011
7 4S p. S219-
1 p.
artikel
1352 In vivo stimulation of macroautophagy: Effect on tau accumulation in neurons and on tau pathology in mutant tau mice Frédérick, Christelle
2011
7 4S p. S507-
1 p.
artikel
1353 In vivo uptake of beta-amyloid stimulates apoptosis of microglia and macrophages, not proliferation Babcock, Alicia
2011
7 4S p. S413-
1 p.
artikel
1354 Involvement of IL-33 in Alzheimer's disease Mounier, Ana's
2011
7 4S p. S392-
1 p.
artikel
1355 Involvement of objective memory loss in the rapid evolution from mild cognitive impairment to Alzheimer's disease Marcos, Alberto
2011
7 4S p. S550-
1 p.
artikel
1356 Involvement of PI3-K pathway and β-catenin signaling in curcumin protecting against Aβ1-42-induced neurotoxicity Hoppe, Juliana Bender
2011
7 4S p. S381-S382
2 p.
artikel
1357 I2PP2A regulates PP2A and GSK-3beta activity and its role in Alzheimer's disease Wang, Jian-Zhi
2011
7 4S p. S411-
1 p.
artikel
1358 IRAK-M deletion activates microglia and restricts cerebral amyloid in PSAPP mice Gate, David
2011
7 4S p. S99-
1 p.
artikel
1359 Iron and copper disarrangements concur in enhancing the risk of Alzheimer's disease Squitti, Rosanna
2011
7 4S p. e16-
1 p.
artikel
1360 Is age-related variance in episodic memory mediated by processing speed or executive function? Lee, Teresa
2011
7 4S p. S252-
1 p.
artikel
1361 Is an altered circadian temperature rhythm associated with behavioral symptoms in nursing home residents with dementia? Woods, Lynn
2011
7 4S p. e53-
1 p.
artikel
1362 Is APOE e4 a risk factor for dementia also among the oldest old? Findings from the Gothenburg 95+ Study Börjesson-Hanson, Anne
2011
7 4S p. S347-
1 p.
artikel
1363 Is apolipoprotein E epsilon4 allele a higher risk factor for Alzheimer's disease than for vascular dementia? A neuropathological study Suemoto, Claudia
2011
7 4S p. e31-
1 p.
artikel
1364 Is Braak stage symmetrical? A pilot study from the Honolulu Asia Aging Study Uyehara-Lock, Jane
2011
7 4S p. e33-
1 p.
artikel
1365 ISISEMD home support in cognitive impairement Mitseva, Anelia
2011
7 4S p. S639-
1 p.
artikel
1366 ISISEMD home support in cognitive impairment Mitseva, Anelia
2011
7 4S p. S678-S679
2 p.
artikel
1367 Is the Arg5His MAPT variant pathogenic for dementia and motor neuron disease? Leverenz, James
2011
7 4S p. S202-S203
2 p.
artikel
1368 Is there any neuropsychological clue in Alzheimer'S and vascular dementia differential diagnosis? Kıral, Kahraman
2011
7 4S p. S248-
1 p.
artikel
1369 Is there a relationship between nonalcoholic fatty liver disease, thyroid pathology and mild cognitive impairment? A Romanian prospective study Ioancio, Ioana
2011
7 4S p. S161-
1 p.
artikel
1370 Is the Romanian population fully aware of the ongoing Alzheimer's crisis? Trascu, Razvan
2011
7 4S p. S443-
1 p.
artikel
1371 Is tissue transglutaminase involved in the development of Alzheimer's disease? Wolf, Johannes
2011
7 4S p. S151-S152
2 p.
artikel
1372 Item and associative encoding in amnestic mild cognitive impairment: a volumetric and functional MRI study Dricot, Laurence
2011
7 4S p. S749-
1 p.
artikel
1373 It really works! Confirmation of the ADNI-based placebo group simulation approach with NACC data Spiegel, René
2011
7 4S p. e64-
1 p.
artikel
1374 “I want to go home”: An identity request expressed by demented persons Meyer, Audrey
2011
7 4S p. S635-
1 p.
artikel
1375 Juvenile dementia and review of pathological findings of very early presenile Alzheimer's disease Rozemuller, Annemieke
2011
7 4S p. S90-S91
2 p.
artikel
1376 Kainic-acid induced neurotoxicity: Role of TNF-α Zhang, Xing-Mei
2011
7 4S p. S532-
1 p.
artikel
1377 Keyword Index 2011
7 4S p. S863-S877
15 p.
artikel
1378 Knowledge translation that puts research-based information in the hands of knowledge users Giles, Cynthia
2011
7 4S p. S501-
1 p.
artikel
1379 KU-046 a dual-acting symptomatic plus disease-modifying drug candidate for treatment of Alzheimer's disease Saxena, Uday
2011
7 4S p. S664-S665
2 p.
artikel
1380 Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins Xiang, Yiwen
2011
7 4S p. S400-
1 p.
artikel
1381 Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Marutle, Amelia
2011
7 4S p. S414-S415
2 p.
artikel
1382 Language and behavior disturbances are associated in moderate but not in advanced dementia Toledo, Cíntia
2011
7 4S p. S267-
1 p.
artikel
1383 Language as an indicator of risk for Alzheimer's disease: Analysis of biographical interviews in preclinical stages Wendelstein, Britta
2011
7 4S p. S602-
1 p.
artikel
1384 Language comprehension in progressive aphasias and atypical parkinsonian syndromes Carthery-Goulart, Maria Teresa
2011
7 4S p. S752-
1 p.
artikel
1385 Late-life widowhood is associated with faster cognitive decline: The Cache County Study. Lee, Hochang
2011
7 4S p. S360-
1 p.
artikel
1386 Late-stage intervention with curcumin reduces soluble tau oligomers and corrects cognitive and synaptic deficits Frautschy, Sally
2011
7 4S p. S299-S300
2 p.
artikel
1387 Left medial temporal volumes and FCSRT cut off scores could be future complementary tools to predict dementia in healthy elderly. Bernard, Charlotte
2011
7 4S p. S417-S418
2 p.
artikel
1388 Left ventricular function and cognitive impairment at age 85 Stessman, Jochanan
2011
7 4S p. S330-S331
2 p.
artikel
1389 Lentiviral delivery of human wild-type Tau protein mediates a slow and progressive spatio-temporal Tau pathology in rat brain Lécolle, Katia
2011
7 4S p. S123-
1 p.
artikel
1390 Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease Perez-Gonzalez, Rocio
2011
7 4S p. S651-
1 p.
artikel
1391 Less common and “disregarded” pathologies in late onset dementia: what are we missing? Keage, Hannah
2011
7 4S p. S606-S607
2 p.
artikel
1392 Lessons from multicenter studies on CSF biomarkers for Alzheimer's disease Blennow, Kaj
2011
7 4S p. S674-
1 p.
artikel
1393 Leukoencephalopathy and microhemorrhages Costa, Sonia
2011
7 4S p. S374-
1 p.
artikel
1394 Licofelone attenuates behavioral, neuroinflammatory and apoptotic alterations against animal models of Huntington's disease Bansal, Puneet
2011
7 4S p. S750-
1 p.
artikel
1395 Life-span of Tau.P301L mice: Modulation by GSK3b and O-GlcNAc-ylation Borghgraef, Peter
2011
7 4S p. S529-S530
2 p.
artikel
1396 Life-span of Tau.P301L mice: Modulation by GSK3b and O-GlcNAcylation Van Leuven, Fred
2011
7 4S p. S506-
1 p.
artikel
1397 Lifestyle behavior typologies predict incident dementia: The Cache County Study. Norton, Maria
2011
7 4S p. S359-S360
2 p.
artikel
1398 Lifestyle, clinical diseases and sociodemographic factors associated to dementia prevalence in Brazilian elderly subjects Barcelos-Ferreira, Ricardo
2011
7 4S p. S591-
1 p.
artikel
1399 Lifetime dietary patterns and longitudinal cognitive outcomes in an older Australian population Hosking, Diane
2011
7 4S p. e45-e46
nvt p.
artikel
1400 Ligustilide alleviates learning dysfunction and brain damage in rats of chronic cerebral hypoperfusion Zhu, Li
2011
7 4S p. S504-
1 p.
artikel
1401 Linking gray matter volume and memory-related activation in the aging brain Burgmans, Saartje
2011
7 4S p. S419-
1 p.
artikel
1402 Lin4Neuro: a customized Linux which enables researchers to share the analysis environment Nemoto, Kiyotaka
2011
7 4S p. S76-S77
2 p.
artikel
1403 Lipid traffic jam in Niemann Pick type C disease causes altered endocytosis of APP Malnar, Martina
2011
7 4S p. S390-
1 p.
artikel
1404 Lipoprotein-associated phospholipase A2 (Lp-PLA2) and risk of dementia in the cardiovascular health study Fitzpatrick, Annette
2011
7 4S p. S296-
1 p.
artikel
1405 Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells Bereczki, Erika
2011
7 4S p. S456-
1 p.
artikel
1406 5-Lipoxygenase and the corticosteroid-dependent abeta formation Puccio, Simone
2011
7 4S p. S402-
1 p.
artikel
1407 Liraglutide, a drug developed to treat type 2 diabetes, has protective effects in mouse models of Alzheimer's disease Platt, Bettina
2011
7 4S p. e59-
1 p.
artikel
1408 Lithium increases mitochondrial function in cultured hippocampal neurons Talib, Leda
2011
7 4S p. S670-
1 p.
artikel
1409 Live cell imaging reveals multiple mechanisms for rapid Amyloid Precursor Protein transport to the lysosome Tang, Weihao
2011
7 4S p. S394-
1 p.
artikel
1410 Live imaging of microtubule disruption and cell toxicity caused by hyperphosphorylated tau Corbo, Christopher
2011
7 4S p. S690-
1 p.
artikel
1411 Liver X receptor agonists and altered cellular cholesterol metabolism modulate APP expression in cerebromicrovascular endothelial cells Schweinzor, Conelea
2011
7 4S p. S128-
1 p.
artikel
1412 Living longer without Alzheimer's disease: A neuropathological study of the individuals Aged ≥ 90 years. Farfel, Jose
2011
7 4S p. S701-
1 p.
artikel
1413 Localization of Hippocampal atrophy in Alzheimer's disease Shen, Kaikai
2011
7 4S p. S343-S344
2 p.
artikel
1414 Localization of hippocampal atrophy in Alzheimer's disease Shen, Kaikai
2011
7 4S p. S17-S18
2 p.
artikel
1415 Longitudinal ADC changes in Alzheimer's disease in a multicenter clinical trial setting Bracoud, Luc
2011
7 4S p. S55-
1 p.
artikel
1416 Longitudinal ADC changes in Alzheimer's disease in a multi-center clinical trial setting Bracoud, Luc
2011
7 4S p. S713-
1 p.
artikel
1417 Longitudinal changes in CSF biomarkers Herukka, Sanna-Kaisa
2011
7 4S p. S103-
1 p.
artikel
1418 Longitudinal changes in fibrillar amyloid-beta deposition across the cognitive spectrum: Effect of the APOE4 allele Cohen, Ann
2011
7 4S p. S698-
1 p.
artikel
1419 Longitudinal changes in left anterior hippocampal activation in cognitively normal subjects with APOE ε4 polymorphism Sridharan, Aadhavi
2011
7 4S p. S225-
1 p.
artikel
1420 Longitudinal cognitive and brain changes in Alzheimer's disease: Effects of age and the APOE-e4 genotype Chang, Yu-Ling
2011
7 4S p. S295-
1 p.
artikel
1421 Longitudinal [11C]PIB PET study in healthy elderly persons, patients with mild cognitive impairment, and Alzheimer's disease Shinotoh, Hitoshi
2011
7 4S p. S224-
1 p.
artikel
1422 Longitudinal evaluation of a standardized job-accompanying qualification concept as dementia care specialist (DE-FA) for nurses and medical teams: Impact on expertise and daily routine in dementia care Holthoff, Vjera
2011
7 4S p. S446-S447
2 p.
artikel
1423 Longitudinal in vivo micro-anatomic followup of amyloid plaque load by MRI Santin, Mathieu
2011
7 4S p. S63-
1 p.
artikel
1424 Longitudinal in vivo micro-anatomic follow-up of amyloid plaque load by MRI Santin, Mathieu
2011
7 4S p. S376-S377
2 p.
artikel
1425 Longitudinal magnetic resonance spectroscopy analysis of APP/PS1 transgenic mice Filibian, Marta
2011
7 4S p. S306-S307
2 p.
artikel
1426 Longitudinal structural MRI changes in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints: relationship to conversion status Risacher, Shannon
2011
7 4S p. S221-S222
2 p.
artikel
1427 Longitudinal volume changes of the hippocampus, parahippocampus and entorhinal cortex improve the prediction of conversion from MCI to Alzheimer's disease Brunton, Simon
2011
7 4S p. e34-e35
nvt p.
artikel
1428 Long-term amnesia following electroconvulsive therapy Lapalus, Pauline
2011
7 4S p. S251-
1 p.
artikel
1429 Long-term effects of a multicomponent cognitive intervention in amnestic mild cognitive impairment (aMCI) Buschert, Verena
2011
7 4S p. S513-S514
2 p.
artikel
1430 Long-term effects of galantamine on cognitive function in alzheimer's disease: A large-scale international retrospective study Schaeuble, Barbara
2011
7 4S p. S788-
1 p.
artikel
1431 Long-term follow up of Alzheimer's patients treated with bapineuzumab in phase 2 Salloway, Stephen
2011
7 4S p. e7-
1 p.
artikel
1432 Long-Term IVIg treatment delays progression of Alzheimer's and lewy body disease Hara, Junko
2011
7 4S p. S461-
1 p.
artikel
1433 Long-term oral lithium treatment attenuates motor disturbance by promoting autophagy in tauopathy model mice Shimada, Kohei
2011
7 4S p. S483-
1 p.
artikel
1434 Long-term results of Alzheimer's disease endovascular treatment method Maksimovich, Ivan
2011
7 4S p. S803-S804
2 p.
artikel
1435 Long-term safety and tolerability of donepezil 23 mg in patients with moderate-to-severe Alzheimer's disease: An 18-month analysis Farlow, Martin
2011
7 4S p. S781-
1 p.
artikel
1436 Loss of tau induces age-dependent neurodegeneration Lei, Peng
2011
7 4S p. e6-
1 p.
artikel
1437 Low CSF Abeta 1-42 is associated with worsening daily functioning in mild cognitive impairment and mild Alzheimer's disease Marshall, Gad
2011
7 4S p. S322-
1 p.
artikel
1438 Low energy laser light (632.8 nm) suppresses amyloid-beta peptide-induced oxidative and inflammatory responses in astrocytes Yang, Xiaoguang
2011
7 4S p. S477-
1 p.
artikel
1439 Lower incidence of new depressive episodes in elderly with subjective cognitive impairment in a cognitive rehabilitation program Xavier, André
2011
7 4S p. S618-
1 p.
artikel
1440 Lowering peripheral Aß is sufficient to reverse cognitive impairment in Tg2576 mice Marti, Anelise
2011
7 4S p. S523-
1 p.
artikel
1441 Lower microglial Fcγ RI/II and macrophage scavenger receptor a in human Alzheimer's disease after Aβ42 immunisation. Zotova, Elina
2011
7 4S p. S684-S685
2 p.
artikel
1442 Low glycine levels in brain homogenates of TgSwDI mice compared to wild-type mice Timmer, Nienke
2011
7 4S p. S529-
1 p.
artikel
1443 Low Prevalence of Apolipoprotein E E4 Allele in Filipinos with Alzheimer’s Disease Casingal, Cristine
2011
7 4S p. S181-
1 p.
artikel
1444 Low serum levels of ApoE associate with hippocampal atrophy in the ADNI cohort Chow, Nicole
2011
7 4S p. S315-
1 p.
artikel
1445 Low serum levels of APOE associate with hippocampal atrophy in the ADNI cohort Chow, Nicole
2011
7 4S p. S23-S24
2 p.
artikel
1446 Low vitamin B12 in the elderly is associated with cortical cognitive profile independently of hyperhomocysteinemia Baptista, Gregory
2011
7 4S p. S534-
1 p.
artikel
1447 LRP10, a new regulator of APP trafficking and processing Brodeur, Julie
2011
7 4S p. e22-e23
nvt p.
artikel
1448 LR11, SNAP25 and SIRT1 Expression: Potential Markers for Alzheimer’s Disease? Smith, Marilia
2011
7 4S p. S196-
1 p.
artikel
1449 Magnetic resonance spectroscopy of 1.28ppm signal in live human brain meets neurogenesis criteria Valenzuela, Michael
2011
7 4S p. S63-S64
2 p.
artikel
1450 Magnitude and Causes of Bias Among Family Caregivers Rating Alzheimer’s Disease Patients Schulz, Richard
2011
7 4S p. S290-S291
2 p.
artikel
1451 Making a national dementia strategy: The Indian experience Kuriakose, Jacob
2011
7 4S p. S628-
1 p.
artikel
1452 Malfunction of HCN channels in X11/X11L doubly deficient mice Saito, Yuhki
2011
7 4S p. S117-
1 p.
artikel
1453 Manipulation endogenous neurotrophic factors: A promising therapy in Alzheimer's disease (hypothetic study) Karimipour, Mohammad
2011
7 4S p. e59-e60
nvt p.
artikel
1454 MAPT study: a 3-year randomized trial of omega 3 and/or multidomain intervention for the prevention of cognitive decline in frail elderly subjects-rationale, design and baseline data Sophie, Gillette Guyonnet
2011
7 4S p. S97-S98
2 p.
artikel
1455 Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease Murray, John
2011
7 4S p. S217-
1 p.
artikel
1456 Maternal history of dementia is associated with amyloid deposition and brain glucose hypometabolism in cognitively normal and mildly impaired elderly Maye, Jacqueline
2011
7 4S p. S234-S235
2 p.
artikel
1457 Maternal Transmission of Alzheimer’s Disease Heggeli, Kristin
2011
7 4S p. S185-
1 p.
artikel
1458 Mathematical modeling of category fluency testing Lerner, Alan
2011
7 4S p. S294-
1 p.
artikel
1459 Matrix Reasoning tasks in presymptomatic progranulin carriers Jacova, Claudia
2011
7 4S p. S766-S767
2 p.
artikel
1460 MCI Incidence, progression to dementia, and reversion to normal in a population-based cohort: The mayo clinic study of aging Roberts, Rosebud
2011
7 4S p. S494-
1 p.
artikel
1461 MCI in Germany: Results from the AgCoDe and the LEILA75+ Study Riedel-Heller, Steffi
2011
7 4S p. S494-
1 p.
artikel
1462 MCI-like pattern of frontal lobe activation in normal elders with impaired saccadic inhibition Boxer, Adam
2011
7 4S p. S682-
1 p.
artikel
1463 MCI markers Chaves, Marcia
2011
7 4S p. S315-
1 p.
artikel
1464 MCI: Occurrence, risk factors, progression—evidence from the Kungsholmen project Fratiglioni, Laura
2011
7 4S p. S495-
1 p.
artikel
1465 Meaningful Activities for Nursing Home Residents with Dementia Kolanowski, Ann
2011
7 4S p. S280-
1 p.
artikel
1466 Measuring of the onset of Alzheimer's Disease and other cognitive dementias in sample surveys: identifying early signs of impairment and the impacts of proxy responses on follow up interviews McNally, James
2011
7 4S p. S441-
1 p.
artikel
1467 Measuring the onset of Alzheimer's Disease and other cognitive dementias in sample surveys: Identifying early signs of impairment and from response patterns in follow-up interviews Sayre, Martha
2011
7 4S p. S444-
1 p.
artikel
1468 Mechanical and analytical techniques to analyze beta sheet formation in the E22G arctic mutant of the Alzheimer's disease Omar, Nadrine
2011
7 4S p. S405-
1 p.
artikel
1469 Mechanism for Aβ reduction with synaptic activity: trafficking of neprilysin to the cell surface and increased co-localization with Aβ42 Tampellini, Davide
2011
7 4S p. S399-
1 p.
artikel
1470 Mechanism for the protective effect of pyrrolidine dithiocarbamate against oxidative stress in AD: induction of the Nrf2-ARE pathway Kanninen, Katja
2011
7 4S p. S797-
1 p.
artikel
1471 Mechanism of action of app translation blockers: From model to human Rogers, Jack
2011
7 4S p. S471-
1 p.
artikel
1472 Mechanism of action of new Alzheimer's therapeutic in phase III clinical trials Mullan, Michael
2011
7 4S p. e61-
1 p.
artikel
1473 Mechanism of action of Posiphen®: From model to human Maccecchini, Maria
2011
7 4S p. S567-S568
2 p.
artikel
1474 Mechanism of mature neuron-specific toxicity induced by high-mass amyloid β-protein assembly with a unique toxic structure Hoshi, Minako
2011
7 4S p. S404-
1 p.
artikel
1475 Mechanisms of tau toxicity in cell and mouse models Mandelkow, Eva
2011
7 4S p. S809-S810
2 p.
artikel
1476 Medial temporal lobe volumes on MRI and neuropathology in autopsy-confirmed Lewy body dementia Burton, Emma
2011
7 4S p. S11-
1 p.
artikel
1477 Medial temporal lobe volumes on MRI and neuropathology in autopsy confirmed Lewy body dementia Burton, Emma
2011
7 4S p. S206-
1 p.
artikel
1478 Medical and Scientific Advisory Council 2011
7 4S p. A8-
1 p.
artikel
1479 Meditation improves depressive symptoms, coping, cognition, and inflammation in family dementia caregivers in a randomized 8-week pilot study Lavretsky, Helen
2011
7 4S p. S436-
1 p.
artikel
1480 Melatonin inhibits α-Synuclein Self-assembly Ono, Kenjiro
2011
7 4S p. S470-
1 p.
artikel
1481 Memantine for agitation in dementia Fox, Chris
2011
7 4S p. e56-e57
nvt p.
artikel
1482 Memantine reverses cognitive deficits induced by total sleep deprivation in O. degus Ros-Bernal, Francisco
2011
7 4S p. S125-
1 p.
artikel
1483 Memantine treatment reduces the intake of concomitant antipsychotics in patients with moderate Alzheimer's disease Ihl, Ralf
2011
7 4S p. S769-
1 p.
artikel
1484 Membrane rafts in the oldest old Hunter, Jesse
2011
7 4S p. S566-
1 p.
artikel
1485 Memogain, a pleasant, highly potent and neuroprotective novel drug treatment in Alzheimer's disease Maelicke, Alfred
2011
7 4S p. S799-
1 p.
artikel
1486 Memory after stroke: Hippocampus and infarcts both matter Blum, Sonja
2011
7 4S p. S418-
1 p.
artikel
1487 Memory, Aging and Cognition Centre's Epidemiology of Dementia in Singapore (EDIS) Study: Study Methodology Venketasubramanian, Narayanaswamy
2011
7 4S p. S362-
1 p.
artikel
1488 Memory awareness influences everyday decision making capacity in Alzheimer's disease Cosentino, Stephanie
2011
7 4S p. e68-
1 p.
artikel
1489 Memory awareness influences everyday decision making capacity in Alzheimer's disease Cosentino, Stephanie
2011
7 4S p. S241-
1 p.
artikel
1490 MemoryCare: A community based dementia care model Noel, Margaret
2011
7 4S p. S635-
1 p.
artikel
1491 Memory decline and cerebrospinal fluid biomarkers in MCI Baldeiras, Ines
2011
7 4S p. S313-
1 p.
artikel
1492 Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease Beyer, Mona
2011
7 4S p. S204-S205
2 p.
artikel
1493 Memory impairment is associated with hippocampal atrophy in newly diagnosed Parkinson's disease Beyer, Mona
2011
7 4S p. S20-S21
2 p.
artikel
1494 Memory Management In Mild Cognitive Impairment Kinsella, Glynda
2011
7 4S p. S278-S279
2 p.
artikel
1495 Memory strategy use in mild cognitive impairment and Alzheimer's disease Medina, Luis
2011
7 4S p. S255-S256
2 p.
artikel
1496 Meta-Analysis of Rare CLU Variants Shows Association With Alzheimer's Risk and Calls Attention To The CLU Beta-Subunit Bettens, Karolien
2011
7 4S p. S93-
1 p.
artikel
1497 Metabolic syndrome and cognitive function in an elderly cohort with memory complaints: A transversal study Duron, Emmanuelle
2011
7 4S p. S351-
1 p.
artikel
1498 Metabolism of mitochondria-associated amyloid precursor protein (APP) Pavlov, Pavel
2011
7 4S p. S404-
1 p.
artikel
1499 Metabolome changes induced by anaesthetic in an in vitro Alzheimer's model. Lloyd, Dafydd
2011
7 4S p. S409-
1 p.
artikel
1500 Metal chaperones: A holistic approach to the treatment of Alzheimer's disease Barnham, Kevin
2011
7 4S p. e54-
1 p.
artikel
1501 Metal complexes for treatment of Alzheimer's disease. Mechanism of their transport through blood brain barrier Salerno, Milena
2011
7 4S p. S472-S473
2 p.
artikel
1502 Methodological issues in clinical trials of Alzheimer's disease Kalali, Amir
2011
7 4S p. S514-
1 p.
artikel
1503 MHC-independent genetic factors control the magnitude of CD4+ T cell responses to amyloid-beta peptide in mice through regulatory T cell-mediated inhibition Toly Ndour, Cécile
2011
7 4S p. S474-S475
2 p.
artikel
1504 Microarray analysis of gene expression profile in astrocytes after exposure to amyloid beta protein Tanaka, Seigo
2011
7 4S p. S399-S400
2 p.
artikel
1505 Microarray analysis of the astrocyte transcriptome in the aging brain: Relationship to Alzheimer's pathology and APOE genotype Simpson, Julie
2011
7 4S p. S566-
1 p.
artikel
1506 Microbleeds, amyloid-beta burden and FDG metabolism in non-demented elderly Gidicsin, Christopher
2011
7 4S p. S698-
1 p.
artikel
1507 Microbleeds do not affect rate of cognitive decline in Alzheimer's disease van der Vlies, Annelies
2011
7 4S p. S745-
1 p.
artikel
1508 Microglia discriminates β-amyloid aggregated species and acquire different activation states Ferrera, Denise
2011
7 4S p. S414-
1 p.
artikel
1509 Microglial RAGE-dependent signal pathway contributes to synaptic dysfunction induced by amyloid and transient ischemia in entorhinal cortex Origlia, Nicola
2011
7 4S p. S393-
1 p.
artikel
1510 MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy Smith, Pascal
2011
7 4S p. e5-
1 p.
artikel
1511 Micro RNA (miRNA) signaling in Alzheimer's disease Lukiw, Walter
2011
7 4S p. S508-
1 p.
artikel
1512 MicroRNA related cofilin abnormality and the pathological consequences in a transgenic mouse model of Alzheimer's disease Yao, Jiaqi
2011
7 4S p. S572-
1 p.
artikel
1513 Microvascular changes associated with passive immunotherapy in PDAPP mice: Potential implication for the etiology of vasogenic edema Zago, Wagner
2011
7 4S p. S531-
1 p.
artikel
1514 Midlife and elderly biologic functions and dementia: Radiation effects research foundation adult health study Yamada, Michiko
2011
7 4S p. S369-
1 p.
artikel
1515 Midlife aspiration and optimism to improve status at work is associated with lower risk for late life dementia Ravona-Springer, Ramit
2011
7 4S p. S600-
1 p.
artikel
1516 Midlife hopelessness and white matter lesions two decades later: A population-based study Hagman, Göran
2011
7 4S p. S595-
1 p.
artikel
1517 Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline Debette, Stéphanie
2011
7 4S p. S512-
1 p.
artikel
1518 Mild cogitive impairment in the 60s Anstey, Kaarin
2011
7 4S p. S681-
1 p.
artikel
1519 Mild Cognitive Impairment and Asymptomatic Lacunar Stroke Cuciureanu, Dan Iulian
2011
7 4S p. S172-
1 p.
artikel
1520 Mild cognitive impairment: Differential atrophy in the hippocampal subfields Hanseeuw, Bernard
2011
7 4S p. S718-
1 p.
artikel
1521 Mild cognitive impairment from the perspective of the medical research council cognitive function and ageing study Stephan, Blossom
2011
7 4S p. S494-S495
2 p.
artikel
1522 Mild cognitive impairment in chronic obstructive pulmonary disease Villeneuve, Sylvia
2011
7 4S p. S268-
1 p.
artikel
1523 Mild cognitive impairment in older Australians from non-English speaking backgrounds Harrison, Fleur
2011
7 4S p. S537-S538
2 p.
artikel
1524 Mild cognitive impairment in Parkinson's disease is associated with white matter damage Canu, Elisa
2011
7 4S p. S751-
1 p.
artikel
1525 Mild cognitive impairment in Parkinson's disease is associated with white matter damage Canu, Elisa
2011
7 4S p. S21-
1 p.
artikel
1526 Mild Dementia evaluated with [11C]DTBZ and [11C]PiB positron emission tomography Gilman, Sid
2011
7 4S p. S110-S111
2 p.
artikel
1527 Mild physical impairment predicts diagnosis of dementia of the Alzheimer type Wilkins, Consuelo
2011
7 4S p. S368-
1 p.
artikel
1528 Mindfulness-based stress reduction for caregivers of patients with Alzheimer's disease Ho, Lap
2011
7 4S p. S431-
1 p.
artikel
1529 Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE in a transgenic model of Alzheimer's-like amyloid pathology Ferretti, Maria Teresa
2011
7 4S p. S652-
1 p.
artikel
1530 Misdiagnosis of depression in patients with selective cognitive deficits: A case study Kosma, Katerina
2011
7 4S p. S757-
1 p.
artikel
1531 Mis-splicing of Tau Exon 2 and Exon 10 in myotonic dystrophy brain would result from different mechanisms Caillet-Boudin, Marie-Laure
2011
7 4S p. S553-
1 p.
artikel
1532 Mitochondria control NMDA receptor-dependent calcium rise evoked by amyloid-β 1-42 oligomers in rat cortical neurons Ferreiro, Elisabete
2011
7 4S p. S580-
1 p.
artikel
1533 Mitochondrial DNA haplogroup, AD incidence, and cognitive function: The Cache County study on memory, health, and aging Kauwe, John
2011
7 4S p. S201-
1 p.
artikel
1534 Mitochondrial DNA sequence variation is associated with cognitive function in the elderly Tranah, Gregory
2011
7 4S p. e31-
1 p.
artikel
1535 Mitochondrial dynamics in Alzheimer's disease Schmitt, Karen
2011
7 4S p. S397-
1 p.
artikel
1536 Mitochondrial fission proteins in peripheral blood lymphocytes: Potential biomarkers for Alzheimer's disease Wang, Shuying
2011
7 4S p. S150-
1 p.
artikel
1537 Mnemosyne: Project helpline for patients diagnosed with dementia and Alzheimer's and their families Catena, Juan
2011
7 4S p. e49-
1 p.
artikel
1538 Mobile phone video: streaming in Alzheimer's disease – an internet: based scheduling system Mason, Sarah
2011
7 4S p. S678-
1 p.
artikel
1539 Mobile phone video streaming in Alzheimer's disease: An internet-based scheduling system Mason, Sarah
2011
7 4S p. S624-
1 p.
artikel
1540 MoCA contributions to differential diagnosis among normal controls, mild cognitive impairment and Alzheimer's disease in Brazil Cecato, Juliana
2011
7 4S p. S535-
1 p.
artikel
1541 Modeling a combination therapy for Alzheimer's disease: Inhibition of secretases and immunotherapy Vivian Chow, Wing Han
2011
7 4S p. e6-
1 p.
artikel
1542 Modeling Alzheimer's disease progression using hidden markov models Sukkar, Rafid
2011
7 4S p. S147-
1 p.
artikel
1543 Modeling the temporal evolution of Alzheimer's pathology with autopsy data Royall, Donald
2011
7 4S p. S303-S304
2 p.
artikel
1544 Modelling Alzheimer's disease through Adeno-Associated Virus (AAV) vector gene delivery in the mouse brain Cacquevel, Matthias
2011
7 4S p. S121-S122
2 p.
artikel
1545 Modifiable factors that decrease or increase the size of hippocampus Fotuhi, Majid
2011
7 4S p. S621-
1 p.
artikel
1546 Modifiers of trajectory to Alzheimer's dementia Bernick, Charles
2011
7 4S p. S347-S348
2 p.
artikel
1547 Modulation of EphB2, but not of cellular prion protein, rescues cognitive functions in a mouse model of Alzheimer's disease Cisse, Moustapha
2011
7 4S p. S773-S774
2 p.
artikel
1548 Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin-administered rats Misra, Shubham
2011
7 4S p. S575-S576
2 p.
artikel
1549 Modulation of oxidative stress and tau phosphorylation by the mTOR activator phosphatidic acid in SH-SY5Y cells Mariko, Taga
2011
7 4S p. S506-S507
2 p.
artikel
1550 Modulation of the intracellular proteolytic cleavage of APP by statins Zhang, Qiang
2011
7 4S p. S380-
1 p.
artikel
1551 Modulation of the microtubule cytoskeleton in a Drosophila model of tauopathy Quraishe, Shmma
2011
7 4S p. S686-
1 p.
artikel
1552 Molecular characterization and preclinical efficacy Dunstan, Robert
2011
7 4S p. S457-
1 p.
artikel
1553 Molecular markers of Alzheimer's Disease pathology and their relationship with default mode network integrity Adriaanse, Sofie
2011
7 4S p. S2-S3
2 p.
artikel
1554 Molecular mechanism of JIP1b-mediated APP association to kinesin-1 in APP transport and metabolic regulation Chiba, Kyoko
2011
7 4S p. S562-
1 p.
artikel
1555 Molecular studies of nicastrin in the γ-Secretase complex using an artificial nicastrin independent presenilin 1 double mutant Svensson, Annelie
2011
7 4S p. S410-S411
2 p.
artikel
1556 Monitoring Daily Life Activity Reveals Less Consumed Calories Among Dementia Patients Iwata, Atsushi
2011
7 4S p. S172-
1 p.
artikel
1557 Monitoring the brain's longitudinal changes in clinical trials for Alzheimer's disease: a robust and reliable non-rigid registration framework Lorenzi, Marco
2011
7 4S p. S376-
1 p.
artikel
1558 Monitoring the Brain’s Longitudinal Changes in Clinical Trials for Alzheimer’s Disease: A Robust and Reliable Nonrigid Registration Framework Lorenzi, Marco
2011
7 4S p. S45-
1 p.
artikel
1559 Monoclonal antibody 3.4A10 reduces Aβ oligomers and attenuates memory impairment in mouse models of Alzheimer's disease Matsumoto, Shin-ei
2011
7 4S p. S466-
1 p.
artikel
1560 6-month chronic study with ponezumab (PF-04360365) Chinese hamster ovary (CHO)-derived murine surrogate in 18-month-old Tg2576 mice Freeman, Gary
2011
7 4S p. S519-
1 p.
artikel
1561 Montreal Cognitive Assessment (MoCA): Diagnostic Utility in a Cognitive Clinic Population Storton, Kathleen
2011
7 4S p. S167-
1 p.
artikel
1562 Morphological and biochemical analysis of the 3xTg-Alzheimer's disease mouse model: Implications for sporadic Alzheimer's disease and the amyloid cascade hypothesis Roher, Alex
2011
7 4S p. S526-
1 p.
artikel
1563 Motivation of dementia patients in seeking initial medical consultation observed by outpatient clinic (initial consultation tends to be late) Shigematsu, Kazuo
2011
7 4S p. S438-
1 p.
artikel
1564 MR elastography of Alzheimer's disease Huston, John
2011
7 4S p. S58-S59
2 p.
artikel
1565 MRI-based biomarkers from hippocampal subfields: Advances in automatic labeling, longitudinal atrophy estimation and postmortem anatomical atlas Das, Sandhitsu
2011
7 4S p. S5-S6
2 p.
artikel
1566 MRI Contrast Agents for Alzheimer’s Disease Diagnosis Based On Magnetic Nanoparticles Fernández, Tamara
2011
7 4S p. e38-
1 p.
artikel
1567 MRI-derived cortical thickness measurements from APP transgenic mice Hebert, Francois
2011
7 4S p. e36-
1 p.
artikel
1568 MRI evaluation of focal brain lesions in streptozotocin-treated animals: Comparison between rodents (rats) and primates (microcebus murinus) Kraska, Audrey
2011
7 4S p. S100-
1 p.
artikel
1569 MRI Markers of Vascular Disease and their Relationship to Cognition Reed, Bruce R.
2011
7 4S p. S284-
1 p.
artikel
1570 mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease Pierce, Anson
2011
7 4S p. S565-
1 p.
artikel
1571 Multicenter, open-label, observational study to assess self care activities of daily living (ADL) in patients with Alzheimer disease with cerebrovascular disease Kim, Yongkyun
2011
7 4S p. S783-
1 p.
artikel
1572 Multicenter study on procedure, feasibility and safety of lumbar puncture in 18 French memory centers Hanon, Olivier
2011
7 4S p. S155-
1 p.
artikel
1573 Multi-decade hippocampal and amygdala volume norms Mouiha, Abderazzak
2011
7 4S p. S142-S143
2 p.
artikel
1574 Multidomain Alzheimer's disease preventive trial: Florbetapir ancillary study. Delrieu, Julien
2011
7 4S p. S419-
1 p.
artikel
1575 Multi-factorial diseases require multi-factorial therapy: Why neglect procaine in neurodegenerative diseases? Turcu, Ileana
2011
7 4S p. S802-
1 p.
artikel
1576 Multifunctional angiotensin II receptor blocker, telmisartan, prevents BBB breakdown and ameliorates cognitive impairment in type 2 diabetes mice with activation of PPAR-gamma Tsukuda, Kana
2011
7 4S p. S117-S118
2 p.
artikel
1577 Multilocus genotype pattern at PICALM, CLU and APOE genes is associated with episodic memory in the NIA-LOAD/NCRAD study Bennett, David A.
2011
7 4S p. S200-S201
2 p.
artikel
1578 Multi-modality fusion of neuroimaging data in predicting abnormal cognitive decline in aging MacCarthy, Matthew
2011
7 4S p. S216-
1 p.
artikel
1579 Multimodality fusion of neuroimaging data in predicting abnormal cognitive decline in aging MacCarthy, Matthew
2011
7 4S p. S30-S31
2 p.
artikel
1580 Multimodality imaging differentiates dementia with lewy bodies from Alzheimer's disease Kantarci, Kejal
2011
7 4S p. S756-
1 p.
artikel
1581 Multimodality imaging differentiates dementia with lewy bodies from Alzheimer's disease Kantarci, Kejal
2011
7 4S p. S14-
1 p.
artikel
1582 Multi-nutrient supplementation induces changes in synaptic protein expression Savelkoul, Paul
2011
7 4S p. S796-
1 p.
artikel
1583 Multi-region analysis of longitudinal FDG-PET enables accurate Alzheimer's disease classification Gray, Katherine
2011
7 4S p. e17-e18
nvt p.
artikel
1584 Multivariate models of Alzheimer's disease progression based on resting-state MEG scans Verdoorn, Todd
2011
7 4S p. S332-S333
2 p.
artikel
1585 Mutations in CODON 716 of the amyloid precursor protein differentially affect APP processing Suarez-Calvet, Marc
2011
7 4S p. S398-S399
2 p.
artikel
1586 Mutual upregulation of IGF-1 and leptin expression prevents their β-amyloid-induced down regulation Marwarha, Gurdeep
2011
7 4S p. S586-
1 p.
artikel
1587 Myelin integrity mediates age-related slowing in cognitive processing speed in a sample of healthy elderly men Lu, Po-Haong
2011
7 4S p. S422-
1 p.
artikel
1588 Myelin integrity mediates age-related slowing in cognitive processing speed in a sample of healthy elderly men Lu, Po-Haong
2011
7 4S p. S68-S69
2 p.
artikel
1589 Naive and pyroglutamated amyloid beta accumulation in the McGill-R-THY1-APP rat model of Alzheimer's disease Canneva, Fabio
2011
7 4S p. e9-
1 p.
artikel
1590 Nardilysin prevents amyloid plaque formation by enhancing alpha-secretase activity in vivo Ohno, Mikiko
2011
7 4S p. S412-
1 p.
artikel
1591 National and sub-national Alzheimer’s plans: A review Splaine, Michael
2011
7 4S p. S633-
1 p.
artikel
1592 Natural flavone, calycopterin, protects differentiated PC12 cells against oxidative stress-induced apoptosis Sarvestani, Nazanin Namazi
2011
7 4S p. S615-
1 p.
artikel
1593 Natural history of A-beta plaque formation: oligomers accumulation precedes fibrillar deposits Myriam, LY
2011
7 4S p. S522-
1 p.
artikel
1594 Natural history of amyloid deposition in Alzheimer's disease associated with PIB PET imaging Hatashita, Shizuo
2011
7 4S p. S82-
1 p.
artikel
1595 Nature and nurture: A golden concept for healthy brain aging Luiza, Spiru
2011
7 4S p. S597-
1 p.
artikel
1596 Near-infrared fluorescence probe X50 for in vivo detection of amyloid plaques in the brain Okamura, Nobuyuki
2011
7 4S p. S62-
1 p.
artikel
1597 Near-infrared spectroscopy: a reliable tool to assess cortical changes in Alzheimer's disease and their progression over time Zeller, Julia
2011
7 4S p. S229-S230
2 p.
artikel
1598 Near-infrared spectroscopy: a reliable tool to assess cortical changes in Alzheimer's disease and their progression over time Zeller, Julia
2011
7 4S p. S42-
1 p.
artikel
1599 Neocortical disconnectivity disrupts semantic binding in Alzheimer's disease Festa, Elena
2011
7 4S p. S244-
1 p.
artikel
1600 Nerve growth factor treatment in Alzheimer's disease: Effects on EEG Eyjolfsdottir, Helga
2011
7 4S p. S652-
1 p.
artikel
1601 Network diffusion accurately predicts atrophy in Alzheimer's Raj, Ashish
2011
7 4S p. S35-S36
2 p.
artikel
1602 Network diffusion accurately predicts atrophy in Alzheimer's Disease Raj, Ashish
2011
7 4S p. S220-
1 p.
artikel
1603 Network efficiency changes in Alzheimer's diease and mild cognitive impairment Reid, Andrew
2011
7 4S p. S743-
1 p.
artikel
1604 Neu-P11, a melatonin/serotonin receptors agonist, protects CA1 pyramidal neurons and cognitive performance in a rat model of Alzheimer, disease Tian, Shaowen
2011
7 4S p. S463-S464
2 p.
artikel
1605 Neural bases of verbal episodic memory impairment in behavioural variant FTD and early onset Alzheimer's disease: a 99m Tc-HMPAO-SPEC-T study Papma, Janne
2011
7 4S p. S342-
1 p.
artikel
1606 Neural correlates of the serial position effects in dementia: A voxel-based morphometry study Foldi, Nancy
2011
7 4S p. S26-
1 p.
artikel
1607 Neural correlates of the stroop test performance in patients with Alzheimer's disease: A FDG-PET study Lee, Dong Young
2011
7 4S p. S739-
1 p.
artikel
1608 Neural correlates of the stroop test performance in patients with Alzheimer's disease: A FDG-PET study Lee, Dong Young
2011
7 4S p. S75-
1 p.
artikel
1609 Neural response to a graded working memory challenge predicts decline in everyday function in mild cognitive impairment Kochan, Nicole
2011
7 4S p. S213-S214
2 p.
artikel
1610 Neural stem cells rescue deficits in Alzheimer's transgenic mice Poon, Wayne
2011
7 4S p. S771-S772
2 p.
artikel
1611 Neural Stem cell transplants LaFerla, Frank
2011
7 4S p. S489-
1 p.
artikel
1612 Neuroanatomical volumes from MRI studies of young, middle-aged, and old APP transgenic mice Hebert, Francois
2011
7 4S p. S307-
1 p.
artikel
1613 Neurochemical profile of SUVN-G1031, a novel histamine H3 receptor antagonist Muddana, Nageswararao
2011
7 4S p. S659-
1 p.
artikel
1614 Neurodegenerative pattern of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) assessed by Diffusion tensor imaging (DTI) in an Indian population Kumari, Rima
2011
7 4S p. S344-S345
2 p.
artikel
1615 Neurogenesis: A new key player in the progression of Alzheimer's disease and its therapeutics Arellano, José Rodríguez
2011
7 4S p. S672-
1 p.
artikel
1616 Neurogenesis in neural progenitor cells is stimulated by potential Alzheimer's drugs Lilja, Anna
2011
7 4S p. S657-
1 p.
artikel
1617 Neurogenic and neuroprotective effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures del Carmen Cardenas-Aguayo, Maria
2011
7 4S p. S651-
1 p.
artikel
1618 Neuroinflammation as an Early Event and Prime Mover in Alzheimer’s Pathobiology Town, Terrence
2011
7 4S p. S285-S286
2 p.
artikel
1619 Neurological side effects due to GSK-3 inhibition by chronic lithium or transgenesis can be prevented by blocking NFAT/Fas pathway Gomez-Sintes, Raquel
2011
7 4S p. S775-
1 p.
artikel
1620 Neuronal correlates underlying the establishment of brain cognitive reserve in a mouse model of Alzheimer's disease Krezymon, Alice
2011
7 4S p. e9-e10
nvt p.
artikel
1621 Neuronal dysfunction and disconnection of cortical hubs in nondemented subjects with elevated amyloid-burden Drzezga, Alex
2011
7 4S p. S72-S73
2 p.
artikel
1622 Neuronal insulin resistance reduces Alzheimer-like pathology in Tg2576 mice independent of Foxo1 mediated transcription Moll, Lorna
2011
7 4S p. S391-
1 p.
artikel
1623 Neuronal nicotinic acetylcholine a4b2 receptor occupancy assay in rats using unlabelled ZW-104 as tracer Bhyrapuneni, Gopinadh
2011
7 4S p. S649-S650
2 p.
artikel
1624 Neuronal tau-specific stress induction of molecular chaperones: The failure of a coping mechanism Abisambra, Jose
2011
7 4S p. S691-
1 p.
artikel
1625 Neurons associated with aggrecan-based perineuronal nets in subcortical regions are not affected by tau pathology in Alzheimer's disease Jäger, Carsten
2011
7 4S p. S702-
1 p.
artikel
1626 Neurons during early development are highly vulnerable to TDP-43 dysregulation Cannon, Ashley
2011
7 4S p. S517-
1 p.
artikel
1627 Neuropathological and biochemical characterization of the oldestold with and without Alzheimer's disease Kokjohn, Tyler
2011
7 4S p. S387-S388
2 p.
artikel
1628 Neuropathologic assessment of ADNI participants: The essential role of the neuropathology core Cairns, Nigel
2011
7 4S p. S699-
1 p.
artikel
1629 Neuropathology associated with administration of a nonselective beta secretase (BACE) and cathepsin D inhibitor in Mdr 1a/b knockout mice Ness, Daniel
2011
7 4S p. S705-
1 p.
artikel
1630 Neuropathology of preclinical and incipient Alzheimer's dementia Taylor-Reinwald, Lisa
2011
7 4S p. S303-
1 p.
artikel
1631 Neurophysiologic effects of memantine in correlation with cognitive and functional abilities of patients with Alzheimer's disease in clinical practice Sallach, Klaus
2011
7 4S p. S654-
1 p.
artikel
1632 Neuroplasticity in dementia following langauge intervention: Illusion of possibliity Jokel, Regina
2011
7 4S p. S754-S755
2 p.
artikel
1633 Neuroprotective and synaptogenic actions of PI3K in an Alzheimer's model in Drosophila Arnes, Mercedes
2011
7 4S p. e27-
1 p.
artikel
1634 Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats de Wilde, Martijn
2011
7 4S p. S795-
1 p.
artikel
1635 Neuroprotective effects of exendin-4 in animal models of Parkinson’s disease Whitton, Peter
2011
7 4S p. S672-
1 p.
artikel
1636 Neuroprotective effects of hypoxic preconditioning on streptozotocin-induced animal model of sporadic Alzheimer's disease Correia, Sónia
2011
7 4S p. S609-
1 p.
artikel
1637 Neuroprotective effects of morroniside against transient forebrain ischemia in the rat cortex Wang, Wen
2011
7 4S p. S126-
1 p.
artikel
1638 Neuroprotective effects of oxazine derivative against LPS-induced oxidative stress via attenuation of NF-κB pathway and regulation of cellular redox status in PC12 cells Shaerzadeh, Fatemeh
2011
7 4S p. S616-S617
2 p.
artikel
1639 Neuropsychatric Sympions and Quality of Life in Patients with very mild and mild aizheimer's disease Koivisto, Anne
2011
7 4S p. S250-
1 p.
artikel
1640 Neuropsychiatric and behavioural symptoms in patients with Alzheimer's disease as an effect to caregivers' state of mental health Uett, Sandra
2011
7 4S p. S626-S627
2 p.
artikel
1641 Neuropsychiatric inventory profile in frontal dementias Papageorgiou, Sokratis
2011
7 4S p. S760-
1 p.
artikel
1642 Neuropsychiatric symptoms and progressive dementia are leading symptoms in a case with mitochondrial cytopathy Topcuoglu, Esen Saka
2011
7 4S p. S762-
1 p.
artikel
1643 Neuropsychiatric Symptoms are Associated with Current and Future Global Functional Impairment in Mild Cognitive Impairment Wadsworth, Lauren Page
2011
7 4S p. S168-S169
2 p.
artikel
1644 Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease Choi, Mun Seong
2011
7 4S p. S550-
1 p.
artikel
1645 Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer's disease Cerveira, Maria Otilia
2011
7 4S p. S429-
1 p.
artikel
1646 Neuropsychiatric symptoms in amnestic mild cognitive impairment: Increased risk and faster progression to dementia Fernandez-Martínez, Manuel
2011
7 4S p. S159-
1 p.
artikel
1647 Neuropsychiatric symptoms in moderate and advanced dementia: Is there a difference? Varandas, Paulo Rogerio
2011
7 4S p. S443-
1 p.
artikel
1648 Neuropsychiatric symptoms of dementia and related caregiver distress: Effects of treatment by a once-daily formulation of Ginkgo biloba Extract EGb 761® Nacu, Anatol
2011
7 4S p. S785-
1 p.
artikel
1649 Neuropsychiatric Syndromes in Dementia and MCI: Where are We Heading? Lyketsos, Constantine
2011
7 4S p. S278-
1 p.
artikel
1650 Neuropsychological correlates of MRI imaging with volumetric analysis in MCI and Alzheimer's disease Watson, G. Stennis
2011
7 4S p. S262-
1 p.
artikel
1651 Neuropsychological differences between apolipoprotein E4 positive and negative subgroups in Alzheimer's disease Shin, Joon Hyun
2011
7 4S p. S265-S266
2 p.
artikel
1652 Neuropsychological markers and circadian salivary cortisol in cognitively normal elderly and two MCI sub profiles: non-amnestic and multidomain. A longitudinal study in Madrid Peraita, Herminia
2011
7 4S p. S550-
1 p.
artikel
1653 Neuropsychological Profiles In Five Subjects With Preclinical FTD-3 Stokholm, Jette
2011
7 4S p. S266-S267
2 p.
artikel
1654 Neuropsychological profiles in mild cognitive impairment and correlation with subcortical vascular lesions in Mexican elderly: A retrospective study Mimenza, Alberto
2011
7 4S p. S542-
1 p.
artikel
1655 New Designs for Assessing Efficacy in Behavioral Treatments in Alzheimer's disease Devanand, Davangere
2011
7 4S p. S487-
1 p.
artikel
1656 New evidence of temporal kinetics of CSF Aβ1-38/1-40/1-42 and phosphorylated tau in seven FAD cases with novel PSEN1 mutations Ikeda, Masaki
2011
7 4S p. e14-
1 p.
artikel
1657 New methods for the analysis of complex diseases Khachaturian, Ara
2011
7 4S p. S656-
1 p.
artikel
1658 New mouse model to develop and test drugs against the human Glutaminyl Cyclase (hQC) for Alzheimer's disease research Molnar, Annamaria
2011
7 4S p. S524-
1 p.
artikel
1659 New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements Clerx, Lies
2011
7 4S p. S209-
1 p.
artikel
1660 New Presenilin Hypothesis Shen, Jie
2011
7 4S p. S677-
1 p.
artikel
1661 NGF and Neuronal Plasticity Cattaneo, Antonino
2011
7 4S p. S489-
1 p.
artikel
1662 NILVAD: An investigator initiated multi-centre placebo-controlled phase III trial of Nilvadipine, a calcium channel blocker, in mild-to-moderate Alzheimer's disease Lawlor, Brian
2011
7 4S p. e60-
1 p.
artikel
1663 No association between presence of carotid disease and 11C-PiB-PET in acute stroke patients Sahathevan, Ramesh
2011
7 4S p. S343-
1 p.
artikel
1664 No Clinically Relevant Effect of BMS-708163, a γ-Secretase Inhibitor, on QTc Interval in Healthy Subjects Tong, Gary
2011
7 4S p. S475-
1 p.
artikel
1665 Non-homogeneous Markov process models with informative observation times, with an application to Alzheimer's disease Chen, Baojing
2011
7 4S p. S369-
1 p.
artikel
1666 Non-melanoma skin cancer is associated with reduced Alzheimer's risk Steinerman, Joshua
2011
7 4S p. S364-
1 p.
artikel
1667 Non-pharmacological intervention: Effectiveness of a multi-component rehabilitation program on cognitive functions of people with mild cognitive impairement Efthymiou, Areti
2011
7 4S p. S643-
1 p.
artikel
1668 Non-pharmacological interventions: An effective tool for dementia or a field which has to be developed? Petsanis, Konstantinos
2011
7 4S p. S260-S261
2 p.
artikel
1669 Noradrenergic sympathetic sprouting in human Alzheimer's and the effect of NGF and Aβ on sympathetic sprouting in cholinergically denervated rats Nelson, Amy
2011
7 4S p. e62-
1 p.
artikel
1670 Normal extracellular Zn++ levels and absence of Ab oligomers at post-synapses mark the hippocampus of individuals with Alzheimer's neuropathology who evade dementia Bjorklund, Nicole
2011
7 4S p. e24-e25
nvt p.
artikel
1671 Normal pressure hydrocephalus: A relevant factor in dementia Xepapadakos, Franziskos
2011
7 4S p. e48-e49
nvt p.
artikel
1672 Normal pressure hydrocephalus: a treatable dementia, a missed diagnosis Razay, George
2011
7 4S p. S371-
1 p.
artikel
1673 Normative data of Fuld Object Memory Evaluation for Brazilian elderly population Nakano, Eduardo
2011
7 4S p. S237-S238
2 p.
artikel
1674 Normative data of the Argentina version of the Boston naming test and discriminative validity for Alzheimer's disease Rojas, Galeno
2011
7 4S p. S262-S263
2 p.
artikel
1675 Normative neuropsychology datasets free from prodromal Alzheimer's disease (AD) cases may improve sensitivity for detecting early cognitive decline: Data from the AIBL study Ellis, Kathryn A.
2011
7 4S p. S158-S159
2 p.
artikel
1676 Notch signaling induces neuronal cell death via the NFkB-Bim pathway in ischemic stroke Choi, Yuri
2011
7 4S p. e47-
1 p.
artikel
1677 Not telling-- policy or protective prevarication?: incorporating advances in Alzheimer's disease research Pierce, Robin
2011
7 4S p. S647-
1 p.
artikel
1678 Novel benzodiazepine receptor ligand AC-4402 is an inverse agonist for GABAAR with pro-cognitive effect in vivo Hatayama, Yuki
2011
7 4S p. S654-S655
2 p.
artikel
1679 Novel Beta-amyloid protein immunoassays Kilheeney, Joseph
2011
7 4S p. S319-
1 p.
artikel
1680 Novel high-field mri applied to the early detection of Alzheimer's disease-related pathology Porchak, Tracy
2011
7 4S p. S723-
1 p.
artikel
1681 Novel high-field MRI applied to the early detection of Alzheimer's disease-related pathology Porchak, Tracy
2011
7 4S p. S62-
1 p.
artikel
1682 Novel, highly translational learning assessment in a mouse model of Alzheimer's disease Montgomery, Karienn
2011
7 4S p. S525-
1 p.
artikel
1683 Novel mechanisms of stress-evoked mood and cognitive impairment - the path from depression to Alzheimer's disease Sotiropoulos, Ioannis
2011
7 4S p. S571-
1 p.
artikel
1684 Novel methods to develop human monoclonal anti-amyloid antibodies that target Aβ aggregates Levites, Yona
2011
7 4S p. S464-
1 p.
artikel
1685 Novel phospho-tau-specific liposome-based vaccines to treat tau pathology Theunis, Clara
2011
7 4S p. S687-
1 p.
artikel
1686 Novel phospho-Tau specific monoclonal antibodies for the treatment of Tau-mediated pathology Adolfsson, Oskar
2011
7 4S p. S480-
1 p.
artikel
1687 Novel prionic and anti-prionic mechanisms in Alzheimer's disease Bredesen, Dale
2011
7 4S p. S509-
1 p.
artikel
1688 Novel public-private partnerships facilitating the development and qualification of biomarkers in Alzheimer's Disease Siuciak, Judith
2011
7 4S p. S329-
1 p.
artikel
1689 Novel Rare Variants in Alzheimer’s Disease Candidate Genes Identified Using Next Generation Sequencing Medway, Christopher
2011
7 4S p. S190-
1 p.
artikel
1690 Novel regulation of BACE1 by retinoid signaling Liao, Francesca-Fang
2011
7 4S p. e23-
1 p.
artikel
1691 Novel roles of Thalidomide in Alzheimer's disease Shen, Yong
2011
7 4S p. S473-
1 p.
artikel
1692 NPT001: A candidate therapeutic for clearance of β-amyloid and tau aggregates in Alzheimer's disease Fisher, Richard
2011
7 4S p. S459-
1 p.
artikel
1693 NPT001: A candidate therapeutic for clearance of beta-amyloid and tau aggregates in Alzheimer's disease Fisher, Richard
2011
7 4S p. e56-
1 p.
artikel
1694 NPT001 reduces Aβ plaque without altering brain interstitial fluid Aβ levels in aged Tg2576 mice Gannon, Kimberley
2011
7 4S p. S459-S460
2 p.
artikel
1695 NSAID use does not affect dementia progression or survival in Alzheimer's disease. The Cache County Dementia Progression Study. Buckley, Trevor
2011
7 4S p. S367-
1 p.
artikel
1696 Nuances in [18F] flutemetamol reader methodology: High inter- and intra reader agreement rates Buckley, Chris
2011
7 4S p. S55-
1 p.
artikel
1697 Nuclear tau protects DNA in stress condition Sultan, Audrey
2011
7 4S p. S507-
1 p.
artikel
1698 Nutritional factors related to the prevention of Alzheimer's disease: a review Piovezan, Ronaldo
2011
7 4S p. S619-
1 p.
artikel
1699 Nutritional status and body composition of in patients with Alzheimer's disease Moriguti, Julio
2011
7 4S p. S447-
1 p.
artikel
1700 Nutritional supplement combination therapy feasibility, safety and biomarker clinical trial in cognitively normal adults Lombardo, Nancy Emerson
2011
7 4S p. S780-S781
2 p.
artikel
1701 Occupational therapy for community-dwelling older people with dementia and their caregivers: From development to implementation Vernooij-Dassen, Myrra
2011
7 4S p. S493-
1 p.
artikel
1702 Occurrence of nonmelanoma skin cancer in the elderly with and without Alzheimer's Disease in the US Wu, Jasmanda
2011
7 4S p. S347-
1 p.
artikel
1703 Olfactory Deficit and Hippocampal Volume Loss for Early Diagnosis of Alzheimer’s Disease Servello, Adriana
2011
7 4S p. S174-
1 p.
artikel
1704 Olfactory function can predict future cognitive decline in healthy, community-dwelling older adults Johnston, Amy
2011
7 4S p. S293-
1 p.
artikel
1705 Olfactory performance and linguistic ability in Alzheimer's disease Lee, Hyeran
2011
7 4S p. S447-
1 p.
artikel
1706 Oligomeric abeta associated with dementia in young-old and oldest-old persons Haroutunian, Vahram
2011
7 4S p. S401-S402
2 p.
artikel
1707 Oligomeric Aβ-targeting D-peptides and peptide-aminopyrazole-hybrids for treatment of Alzheimer's disease Bartnik, Dirk
2011
7 4S p. S456-
1 p.
artikel
1708 Omega-3 Fatty Acids and the brain Cunnane, Stephen
2011
7 4S p. S88-
1 p.
artikel
1709 Omega-3 polyunsaturated fatty acids and mixed dementia Culum, Ivan
2011
7 4S p. S651-S652
2 p.
artikel
1710 One-year survival of demented stroke patients in the Dijon stroke registry (1985-2008) Béjot, Yannick
2011
7 4S p. S604-S605
2 p.
artikel
1711 On the mechanisms regulating synaptic vesicle release by endogenous amyloid-beta peptides Fogel, Hilla
2011
7 4S p. S582-
1 p.
artikel
1712 Oophorectomy and risk of dementia Chuang, Yifang
2011
7 4S p. S592-
1 p.
artikel
1713 “Open House” Screening Program to Identify Cognitive Impairment Among Community-Dwelling Middle-Aged/Elderly People Vinyes-Junque, Georgina
2011
7 4S p. S171-
1 p.
artikel
1714 Ophthalmic impairments or higher order visual deficits? Posterior cortical atrophy: a case report Ruis, Carla
2011
7 4S p. S276-
1 p.
artikel
1715 Opposing structural effects of glycosylation and phosphorylation on tau Zondlo, Neal
2011
7 4S p. e25-
1 p.
artikel
1716 Optimized ROI measures of FDG-PET improve characterization of early cognitive impairment and are comparable to PIB-PET Lowe, Val
2011
7 4S p. S16-
1 p.
artikel
1717 Optimized ROI measures of FDG—PET improve characterization of early cognitive impairment and are comparable to PIB—PET Lowe, Val
2011
7 4S p. S341-
1 p.
artikel
1718 Oral and written narrative discourse in Alzheimer's disease Ortiz, Karin
2011
7 4S p. S759-
1 p.
artikel
1719 Oral vaccine using viral vectors for Alzheimer's disease: PIB/PET studies in old cynomolgus monkeys Tabira, Takeshi
2011
7 4S p. S474-
1 p.
artikel
1720 Orange county vital aging program: A community-based approach to reduce impact of Alzheimer's disease on health care resources Shankle, William
2011
7 4S p. S617-
1 p.
artikel
1721 Ordering of Alzheimer's disease biomarkers Jack, Clifford
2011
7 4S p. S4-S5
2 p.
artikel
1722 ORL1: A Novel Mechanism With Potential to Provide Beneficial Effects for Depressive Symptoms Associated With Alzheimer's Disease (AD) Iyer, Rathna
2011
7 4S p. S769-
1 p.
artikel
1723 Our experience when treating early and moderate Alzheimer's disease with donepezil Gavrilovic, Aleksandar
2011
7 4S p. e57-
1 p.
artikel
1724 Outcomes of MCI: The Mayo Clinic study of aging Roberts, Rosebud
2011
7 4S p. S551-
1 p.
artikel
1725 Outcomes of the progressively lowered stress threshold intervention on depression and burden in AD Alzheimer’s caregivers Robinson, Karen
2011
7 4S p. S436-
1 p.
artikel
1726 Overdiagnosis of vascular dementia using structural brain imaging in the context of standard clinical diagnostic criteria Engelborghs, Sebastiaan
2011
7 4S p. S338-S339
2 p.
artikel
1727 Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate Abeta production, induces behavioral deficits and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice Jawhar, Sadim
2011
7 4S p. S478-
1 p.
artikel
1728 Overexpression of inositol 1,4,5-trisphosphate 3-kinase B (Itpkb) in neurons of APP mice leads to an increase of Amyloid Beta production. Stygelbout, Virginie
2011
7 4S p. S528-S529
2 p.
artikel
1729 Overexpression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase in triple-transgenic (3xTg) Alzheimer's disease mouse brain Wu, Wei
2011
7 4S p. S530-
1 p.
artikel
1730 Over-time reliability of MTA grading in a clinical setting Cavallin, Lena
2011
7 4S p. S47-S48
2 p.
artikel
1731 Overview and preliminary results of the 3 LM-AD study: Comparison of 3 Learning techniques in Alzheimer disease Dechamps, Arnaud
2011
7 4S p. S779-S780
2 p.
artikel
1732 Overview of Statistical Methods in Alzheimer’s Trial with Concentration on Disease Modification Effects Entsuah, Rihard
2011
7 4S p. S170-
1 p.
artikel
1733 Oxidation of LRP in The Alzheimer's brain Owen, Josh
2011
7 4S p. S808-
1 p.
artikel
1734 Oxidative stress, amyloid metabolism and Alzheimer's pathogenesis: Extrapolation of a cell-based study Sinha, Maitrayee
2011
7 4S p. S576-
1 p.
artikel
1735 Oxidative stress-induced mitochondrial DNA overproliferation and deletion, cellular hypoperfusion and brain hypometabolism in the context of Alzheimer's disease: past, present and future Aliev, Gjumrakch
2011
7 4S p. S305-
1 p.
artikel
1736 Oxysterols, Blood-Brain Barrier (BBB) and Alzheimer's Disease: in vitro studies on endothelial cells and pericytes Saint-Pol, Julien
2011
7 4S p. S396-S397
2 p.
artikel
1737 Paired associative learning is related to amyloid deposition in normal older individuals. Wadsworth, Lauren
2011
7 4S p. S293-
1 p.
artikel
1738 Palliative care for people with dementia: Aged care staff perspectives Davis, Sandra
2011
7 4S p. e50-
1 p.
artikel
1739 Parietal lobe changing is important for Alzheimer's disease diagnosis Gao, Jing
2011
7 4S p. e35-e36
nvt p.
artikel
1740 Parietal lobe white matter hyperintensities but not hippocampal volume predict incident dementia Brickman, Adam
2011
7 4S p. S301-
1 p.
artikel
1741 Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in alzheimer's DISEASE models Khandelwal, Preeti
2011
7 4S p. S468-
1 p.
artikel
1742 Passive immunization of P301L mice with two different tau monoclonal antibodies D'Abramo, Cristina
2011
7 4S p. S481-
1 p.
artikel
1743 Pathogenesis of vascular dementia Nwankwo, Innocent
2011
7 4S p. S705-S706
2 p.
artikel
1744 Pathogenic action of homocysteic acid in human Hasegawa, Tohru
2011
7 4S p. S565-
1 p.
artikel
1745 Pathological correlates of white matter hyperintensities on magnetic resonance imaging Shim, YongSoo
2011
7 4S p. S706-
1 p.
artikel
1746 Pathologically confirmed frontal variant alzheimerâś disease: Two cases and review of the literature Villarejo, Alberto
2011
7 4S p. S709-
1 p.
artikel
1747 Pathologically proven Alzheimer's disease without medial temporal lobe atrophy: The importance of posterior cerebral atrophy Lehmann, Manja
2011
7 4S p. S15-
1 p.
artikel
1748 Pathologically-Proven Alzheimer's Disease Without Medial Temporal Lobe Atrophy: The Importance of Posterior Cerebral Atrophy Lehmann, Manja
2011
7 4S p. S340-S341
2 p.
artikel
1749 Pathological outcome of APP and tau interaction in the entorhinal cortex Elizabeth, Karen
2011
7 4S p. S809-
1 p.
artikel
1750 Pathological role of cytochrome P450 2D6 in dementia with Lewy bodies Tanaka, Seigo
2011
7 4S p. S763-
1 p.
artikel
1751 (Patho)physiological consequences of interactions of amyloid-β with cellular and non-cellular proteins; the role of “The Crossbeta Pathway”. Gebbink, Martijn
2011
7 4S p. S385-
1 p.
artikel
1752 Patients' and caregivers' willingness to pay for a new Alzheimer's disease medication Oremus, Mark
2011
7 4S p. S645-S646
2 p.
artikel
1753 Patients' attitudes and acceptance of dementia screening in primary care Fowler, Nicole
2011
7 4S p. S452-S453
2 p.
artikel
1754 Patterns of cortical and subcortical atrophy in early-onset and late-onset Alzheimer's disease Frisoni, Giovanni
2011
7 4S p. S89-S90
2 p.
artikel
1755 Patterns of 18F-FDG PET in different subtypes of Alzheimer' disease Haense, Cathleen
2011
7 4S p. S735-
1 p.
artikel
1756 Patterns of 18F-FDG PET in different subtypes of Alzheimer' disease Haense, Cathleen
2011
7 4S p. S74-
1 p.
artikel
1757 Peptide vaccines for treatment of Alzheimer's disease - characterization of T-cell epitope-dependent immune response in wild-type mice Richter, Monique
2011
7 4S p. S663-S664
2 p.
artikel
1758 Peptide vaccines for treatment of Alzheimer's disease: immunization trails in transgenic P301S and Tg2576 mice Singer, David
2011
7 4S p. S666-
1 p.
artikel
1759 Perceived marital problems in midlife are associated with cognitive health in later life Hakansson, Krister
2011
7 4S p. S595-
1 p.
artikel
1760 Perception of well being predicts incident harm in cognitively impaired seniors who live alone: A prospective study Tierney, Mary
2011
7 4S p. S499-
1 p.
artikel
1761 Perceptions and attitudes in Alzheimer disease caregivers in Greece: a cross-sectional study Sakka, Paraskevi
2011
7 4S p. S437-
1 p.
artikel
1762 Performance-based and self-rated everyday functioning in persons with mild cognitive impairment Lin, Feng
2011
7 4S p. S541-
1 p.
artikel
1763 Periodontal inflammation effect on cognition depends on the IL-10-1082 gene polymorphism Kamer, Angela
2011
7 4S p. S320-S321
2 p.
artikel
1764 Peripheral amyloid-beta mobilization with the intravenous immunoglobulin Flebogamma DIF® in Alzheimer's disease patients Rovira, Mercè Boada
2011
7 4S p. S456-S457
2 p.
artikel
1765 Peripheral and central responses of kynurenine pathway in response to low and high tryptophan-containing food in rhesus macaques McCampbell, Alexander
2011
7 4S p. S124-
1 p.
artikel
1766 Peripheral blood gene expression correlates of cortical atrophy across cognitively normal elderly and MCI Apostolova, Liana
2011
7 4S p. S311-S312
2 p.
artikel
1767 Peripheral Blood Gene Expression Correlates of Cortical Atrophy Across in Cognitively Normal Elderly and MCI Apostolova, Liana
2011
7 4S p. S46-
1 p.
artikel
1768 Peripheral clearance of intravenously injected Aß42 is APOE genotype-specific in chow-fed mice but not cholesterol-fed mice Morici, Michael
2011
7 4S p. S99-
1 p.
artikel
1769 Peripheral oxidative stress in sporadic Alzheimer's disease Ashok, Ben
2011
7 4S p. S336-S337
2 p.
artikel
1770 Peripheral white blood cell count may be diminished in familial Alzheimer's disease mutation carriers Ringman, John
2011
7 4S p. S326-S327
2 p.
artikel
1771 Perivascular drainage of Aβ is disrupted in the brains of mice expressing the human apolipoprotein E4 allele Hawkes, Cheryl
2011
7 4S p. e70-
1 p.
artikel
1772 Periventricular white matter lesions in early Lewy body dementia Oppedal, Ketil
2011
7 4S p. S217-S218
2 p.
artikel
1773 Periventricular white matter lesions in early lewy body dementia Oppedal, Ketil
2011
7 4S p. S33-
1 p.
artikel
1774 Perlecan's domain V prevents amyloid-beta toxicity Parham, Christi
2011
7 4S p. S584-
1 p.
artikel
1775 Personality and cognitive decline: Results from the Einstein aging study Katz, Mindy
2011
7 4S p. S539-
1 p.
artikel
1776 Personality in Alzheimer's Disease Boothby, Harry
2011
7 4S p. S348-S349
2 p.
artikel
1777 Perspective on the role of the amyloid beta oligomer in Alzheimer's disease Mori, Hiroshi
2011
7 4S p. S83-
1 p.
artikel
1778 PET and tissue autoradiography evidence of decline of metabotropic glutamate receptor type 5 (mGluR5) in the prefrontal cortex of Alzheimer's disease Rosa-Neto, Pedro
2011
7 4S p. S111-
1 p.
artikel
1779 PET imaging of Alzheimer’s transgenic mice at an early age with F-18 quinoline Kulkarni, Padmakar
2011
7 4S p. S214-
1 p.
artikel
1780 PET imaging of Alzheimer's transgenic mice at an early age with F-18 quinoline Kulkarni, Padmakar
2011
7 4S p. S9-
1 p.
artikel
1781 PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 together distinguish Alzheimer's disease from DLB patients Sabbagh, Marwan
2011
7 4S p. S342-S343
2 p.
artikel
1782 PET imaging with BF-227 in dementia with Lewy bodies Furukawa, Katsutoshi
2011
7 4S p. S12-S13
2 p.
artikel
1783 PET scanner difference and correction using normal data in multicenter brain FDG-PET studies Nagai, Hidehito
2011
7 4S p. S61-
1 p.
artikel
1784 PF-04447943: A phase II controlled clinical trial of a selective PDE9A inhbitor in Alzheimer's disease Schwam, Elias
2011
7 4S p. S695-
1 p.
artikel
1785 Pharmacokinetic and safety interactions between a novel PDE9 inhibitor, PF-04447943, and donepezil in healthy volunteers Nicholas, Timothy
2011
7 4S p. S786-
1 p.
artikel
1786 Pharmacokinetics and pharmacodynamics following γ-secretase modulator and inhibitor treatment of Cynomolgus monkeys (Macaca fascicularis) Van Broeck, Bianca
2011
7 4S p. S148-
1 p.
artikel
1787 Pharmacokinetics, safety and tolerability of PF-04995274: A 5HT4 partial agonist being developed for the treatment of Alzheimer's disease Nicholas, Timothy
2011
7 4S p. S786-S787
2 p.
artikel
1788 Phenylquinoline derivatives for in vivo imaging of tau pathology in Alzheimer's disease Okamura, Nobuyuki
2011
7 4S p. e38-
1 p.
artikel
1789 Phosphodiesterase 7 inhibitor S14 regulates astrocytes-induced degradation of brain degradation of brain amyloid-β Perez-Gonzalez, Rocio
2011
7 4S p. S457-
1 p.
artikel
1790 Phospho-Tau SRM: a multi-site phosphorylation assay for assessing mouse models and drug development in Alzheimer's disease Schofield, Emma
2011
7 4S p. S328-
1 p.
artikel
1791 Phylogenetic mapping of phased haplotype data for post-GWAS mapping Roses, Allen
2011
7 4S p. e29-
1 p.
artikel
1792 Physical activity and a home-based exercise program to improve cognitive function and balance in the elderly with mild cognitive impairment: Yangcheon Gold Campaigne Kim, Jung Eun
2011
7 4S p. S620-S621
2 p.
artikel
1793 Physical activity and cognition: Effect at mid-life versus late life Middleton, Laura
2011
7 4S p. S614-
1 p.
artikel
1794 Physical activity and dementia prevention: what type of physical activity is really effective? Schröder, Johannes
2011
7 4S p. S96-
1 p.
artikel
1795 Physical activity, including waking, in relation to cognitive decline in women with cerebrovascular disease or vascular factors Vercambre, Marie-Noel
2011
7 4S p. S511-
1 p.
artikel
1796 Physical activity is predictive of dementia but not mortality Garcia, Jeanette
2011
7 4S p. S605-
1 p.
artikel
1797 Phyto-beta-SERM formulation for menopause and Alzheimer's disease: From bench to bedside Zhao, Liqin
2011
7 4S p. S669-
1 p.
artikel
1798 PIB retention changes in cognitively normal, mild cognitive impairment and Alzheimer's disease: One year follow-up study Choo, Il Han
2011
7 4S p. S208-S209
2 p.
artikel
1799 PICALM single nucleotide polymorphisms are associated with CSF Aβ1-42 levels in patients with Alzheimer's dementia Faltraco, Frank
2011
7 4S p. S497-S498
2 p.
artikel
1800 Picomolar Beta-Amyloid progressively impairs synaptic plasticity over time while simultaneously increases spontaneous neurotransmission Fa, Mauro
2011
7 4S p. S586-
1 p.
artikel
1801 Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of Alzheimer's disease Egan, Michael
2011
7 4S p. S300-
1 p.
artikel
1802 Pitavastatin decreases tau levels via the inactivation of Rho family small G proteins Hamano, Tadanori
2011
7 4S p. S583-
1 p.
artikel
1803 Placebo-controlled trial of quetiapine for sleep disturbance in AD Singer, Clifford
2011
7 4S p. S773-
1 p.
artikel
1804 Planning abilities in aging, mild cognitive impairment and Alzheimer's disease patients Fernandez-Guinea, Sara
2011
7 4S p. S243-S244
2 p.
artikel
1805 Planning the Generation of Items on the Verbal Fluency Test is Crucial to the Final Result Steiner, Veronique Guernet
2011
7 4S p. S168-
1 p.
artikel
1806 Plasma Aβ and PET PIB binding are inversely related in mild cognitive impairment Devanand, Davangere
2011
7 4S p. S733-S734
2 p.
artikel
1807 Plasma amyloid-beta as a predictor of dementia and cognitive decline: A systematic review and meta-analysis Koyama, Alain
2011
7 4S p. S318-
1 p.
artikel
1808 Plasma β-amyloid protein and serum β-amyloid autoantibodies levels in patients with Alzheimer's disease Zhou, Lin
2011
7 4S p. S152-S153
2 p.
artikel
1809 Plasma and Cerebrospinal Fluid Markers in the DIAN Study of Autosomal-Dominant Alzheimer’s Disease Fagan, Anne
2011
7 4S p. S287-
1 p.
artikel
1810 Plasma and cerebrospinal fluid markers in the DIAN study of autosomal-dominant Alzheimer's disease Fagan, Anne
2011
7 4S p. S679-S680
2 p.
artikel
1811 Plasma apolipoproteins as biomarkers of mild cognitive impairment in a community-based sample Song, Fei
2011
7 4S p. S146-
1 p.
artikel
1812 Plasma BDNF associations with cortical thickness in normal controls and mild cognitive impairment Hwang, Kristy
2011
7 4S p. S319-
1 p.
artikel
1813 Plasma copper and ceruloplasmin are not altered in Alzheimer's disease: Baseline data in the Australian Imaging Biomarker Lifestyle (AIBL) study of Ageing Rembach, Alan
2011
7 4S p. S144-
1 p.
artikel
1814 Plasma F2 isoprostanes and dementia : Results from a longitudinal study Berr, Claudine
2011
7 4S p. S348-
1 p.
artikel
1815 Plasma long-chain omega-3 fatty acids and medial temporal lobe atrophy: a longitudinal MRI study Samieri, Cécilia
2011
7 4S p. S363-
1 p.
artikel
1816 Plasma multianalyte profiling of mild cognitive impairment and Alzheimer's disease in two academic centers and the Alzheimer's Disease Neuroimaging Initiative Hu, William T.
2011
7 4S p. S138-
1 p.
artikel
1817 Plasma neopterin levels in a MCI and Alzheimer's disease Oh, Esther
2011
7 4S p. S143-
1 p.
artikel
1818 Plasma protein associations with hippocampal atrophy across the cognitive spectrum from normal aging to Alzheimer's disease Chow, Nicole
2011
7 4S p. S315-S316
2 p.
artikel
1819 Plasma sphingomyelin is associated with cognitive progression in Alzheimer's Disease Mielke, Michelle
2011
7 4S p. S322-S323
2 p.
artikel
1820 Plasma urate in patients with Alzheimer's disease Said Ramdane,
2011
7 4S p. S153-
1 p.
artikel
1821 Platelet PLA2 activity in patients with mild cognitive impairment: a longitudinal study Talib, Leda
2011
7 4S p. S331-
1 p.
artikel
1822 Polymorphisms of CR1, CLU and PICALM Confer Susceptibility of Alzheimer’s Disease in Southern Chinese Population Chen, Lu Hua
2011
7 4S p. S181-
1 p.
artikel
1823 Polymorphism strongly associated with PSP alters MAPT transcription Kay, Victoria
2011
7 4S p. S555-
1 p.
artikel
1824 Polyunsaturated fatty acids status is associated with depressive symptoms in Alzheimer's disease Takano, Daiki
2011
7 4S p. S148-
1 p.
artikel
1825 Population pharmacokinetic analysis of plasma, cerebrospinal fluid and brain ELND005 in patients with mild to moderate Alzheimer's disease Wagg, Jonathan
2011
7 4S p. S475-
1 p.
artikel
1826 Positional cloning identifies SIGMAR1 gene as a causative locus for FTLD-MND in a large Australian pedigree Kwok, John
2011
7 4S p. S202-
1 p.
artikel
1827 Possible role of N-acetyl cysteine against aluminum-induced cognitive dysfunction and oxidative damage in rats Kumar, Anil
2011
7 4S p. S614-
1 p.
artikel
1828 Posterior compensatory network mediates spatial working memory in those with proficient cognition despite hippocampal atrophy Valenzuela, Michael
2011
7 4S p. e41-e42
nvt p.
artikel
1829 Posterior cortical atrophy with acute onset and rapid progressive visual symptoms Kwon, Yooseok
2011
7 4S p. S757-S758
2 p.
artikel
1830 Post-mortem beta-amyloid plaques correlate with frontal cortical biopsy findings Leinonen, Ville
2011
7 4S p. S704-
1 p.
artikel
1831 Postsynaptic protein PSD-95 expression is correlated to clinical indexes in the anterior cingulate and frontal cortex of Alzheimer's disease cases Leuba, Geneviève
2011
7 4S p. S704-
1 p.
artikel
1832 Potential Alzheimer's treatments GM-CSF and G-CSF improve cognition in cancer patients Potter, Huntington
2011
7 4S p. S514-
1 p.
artikel
1833 Potential effect of curcumin against neuronal death in rat prefrontal cortex through antagonizing staurosporine toxicity Wang, HongZheng
2011
7 4S p. S667-
1 p.
artikel
1834 Potential of PET to predict cognitive decline along the continuum of Alzheimer's disease Ossenkoppele, Rik
2011
7 4S p. S742-
1 p.
artikel
1835 Potentiation of depolarization-induced glutamate release in young FAD mutant hAPP mice Sokolow, Sophie
2011
7 4S p. S528-
1 p.
artikel
1836 PPAR gamma/RXR induced and CD36-mediated Abeta phagocytosis results in cognitive improvement in APP/PS1 mice Yamanaka, Mitsugu
2011
7 4S p. S401-
1 p.
artikel
1837 Preclinical Dementia in Different Populations Laukka, Erika
2011
7 4S p. S281-
1 p.
artikel
1838 Preclinical development of allopregnanolone to restore cognitive function in a mouse model of Alzheimer's disease: transdermal and intranasal drug delivery She, Hongyun
2011
7 4S p. S477-S478
2 p.
artikel
1839 Preclinical development of new tetrahydrofurannes derivatives as neuroprotectants targeting the sigma-1 chaperone protein in Alzheimer's disease Maurice, Tangui
2011
7 4S p. S658-
1 p.
artikel
1840 Preclinical efficacy of 2-Deoxyglucose to sustain mitochondrial metabolic function and delay progression of Alzheimer's pathology Yao, Jia
2011
7 4S p. S667-S668
2 p.
artikel
1841 Preclinical Vascular Cognitive Impairment Erkinjuntt, Timo
2011
7 4S p. S280-S281
2 p.
artikel
1842 Predicting brain amyloid-β burden with atrophy in MCI Tosun, Duygu
2011
7 4S p. S236-
1 p.
artikel
1843 Predicting cognitive decline in MCI subjects using the fusion ICA toolbox to combine multimodality neuroimaging data Shaffer, Jennifer
2011
7 4S p. S38-
1 p.
artikel
1844 Predicting cognitive decline in MCI subjects using the Fusion ICA Toolbox to combine multimodality neuroimaging data Shaffer, Jennifer
2011
7 4S p. S545-
1 p.
artikel
1845 Predicting initial changes in brain volume with effective anti-amyloid agents: Just ask alice Cedarbaum, Jesse
2011
7 4S p. S377-S378
2 p.
artikel
1846 Predicting Initial Changes in Brain Volume with Effective Anti-Amyloid Agents: Just Ask Alice Cedarbaum, Jesse
2011
7 4S p. S46-
1 p.
artikel
1847 Predicting MCI or dementia at follow-up: Using subjective memory and non-memory complaints from both the participant and informant Slavin, Melissa
2011
7 4S p. S546-
1 p.
artikel
1848 Predicting progression to Alzheimer's disease in MCI using combined structural atrophy and CSF biomarkers McEvoy, Linda K.
2011
7 4S p. S107-S108
2 p.
artikel
1849 Predicting progression to Alzheimer's Disease in MCI using combined structural imaging and CSF biomarkers McEvoy, Linda
2011
7 4S p. S3-S4
2 p.
artikel
1850 Predicting the onset of Alzheimer's disease with a behavioral task Zola, Stuart
2011
7 4S p. S549-
1 p.
artikel
1851 Prediction of MCI converters in the ADNI cohort using patterns of cortical thinning Eskildsen, Simon
2011
7 4S p. S211-
1 p.
artikel
1852 Prediction of MCI converters in the ADNI cohort using patterns of cortical thinning Eskildsen, Simon
2011
7 4S p. S25-
1 p.
artikel
1853 Prediction of MCI to Alzheimer's conversion with hippocampal shape features and support vector machine Young, Jonathan
2011
7 4S p. S41-
1 p.
artikel
1854 Predictive accuracy for Alzheimer's Disease of CSF Aß1-42, hippocampal atrophy and APOE genotype in MCI subjects depends on age van Rossum, Ineke
2011
7 4S p. S108-
1 p.
artikel
1855 Predictors for cognitive decline in patients with confluent white matter hyperintensities Mok, Vincent
2011
7 4S p. S619-S620
2 p.
artikel
1856 Predictors of cognitive decline at 18 month follow up among 1112 participants in the Australian imaging, biomarkers and lifestyle flagship study of ageing (AIBL) Ellis, Kathryn A.
2011
7 4S p. S158-
1 p.
artikel
1857 Predictors of resilient cognitive aging: Baseline characteristics Steinberg, Susanne
2011
7 4S p. S605-S606
2 p.
artikel
1858 Predictors to long-term treatment response to galantamine Schaeuble, Barbara
2011
7 4S p. S665-
1 p.
artikel
1859 Prefrontal lateralization during a verbal fluency task predicts neuropsychological changes in healthy elderly controls: a fNIRS study Zeller, Julia
2011
7 4S p. S229-
1 p.
artikel
1860 Prefrontal lateralization during a verbal fluency task predicts neuropsychological changes in healthy elderly controls: a fNIRS study Zeller, Julia
2011
7 4S p. S41-S42
2 p.
artikel
1861 Preliminary evaluation of the amyloid PET Radioligand [18F]MK-3328 in Alzheimer's Disease patients Sanabria-Bohorquez, Sandra
2011
7 4S p. S319-
1 p.
artikel
1862 PreMCI, eMCI and aMCI: Comparison of imaging features, APOE frequencies and progression rates to dementia Loewenstein, David
2011
7 4S p. S541-
1 p.
artikel
1863 Preparedness for the Caregiving Role: A Protective Factor Against Depression and the Desire to Institutionalise Our Older Caregivers Mhaolain, Aine Ni
2011
7 4S p. S437-
1 p.
artikel
1864 Prescription omega-3 fatty acid-induced prevention of impairment of memory learning in amyloid-beta-infused rats associates with the decrease of amyloid-beta levels in detergent-insoluble membrane fractions Hashimoto, Michio
2011
7 4S p. S610-
1 p.
artikel
1865 Presence of SET in the cytoplasm in two in vitro models is not always associated with its cleavage but induces tau hyperphosphorylation Chasseigneaux, Stéphanie
2011
7 4S p. S553-S554
2 p.
artikel
1866 Presenilin and gamma-secretase control kinesin-1 and dynein activity in axonal transport Gunawardena, Shermali
2011
7 4S p. S104-S105
2 p.
artikel
1867 Presenilin-2 modulates ER-mitochondria interactions and Ca2+ cross-talk: effects of its FAD-linked mutations Zampese, Enrico
2011
7 4S p. S508-
1 p.
artikel
1868 Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Cu/Zn-Dependent Superoxide Dismutase Activtity Greenough, Mark
2011
7 4S p. S186-
1 p.
artikel
1869 Presentation of ADAS cog test with delayed recall and semantic encoding during the learning phase: Results in normal, MCI and dementia population Labos, Edith
2011
7 4S p. S250-S251
2 p.
artikel
1870 Pre-stroke and post-stroke dementia: Preliminary data from an Italian study Rozzini, Luca
2011
7 4S p. S762-
1 p.
artikel
1871 Prevalence of cerebral microhemorrhages at screening in an Alzheimer's disease clinical trial population Lobello, Kasia
2011
7 4S p. S234-
1 p.
artikel
1872 Prevalence of cognitive impairment of elderly living in an isolated community, a descendent of slaves, in central Brazil Lopes, Danielly
2011
7 4S p. S253-S254
2 p.
artikel
1873 Prevalence of dementia in the elderly from different levels of health care Rodrigues, Thiago
2011
7 4S p. S372-
1 p.
artikel
1874 Prevalence of vasogenic edema and microhemorrhage in an Alzheimer's disease study population at baseline Carlson, Christopher
2011
7 4S p. S732-
1 p.
artikel
1875 Preventing cognitive decline in the elderly through physical activity in midlife Clifford, Angela
2011
7 4S p. S95-S96
2 p.
artikel
1876 Prevention of amyloid β-peptide fibrillation by the BRICHOS domain Presto, Jenny
2011
7 4S p. S616-
1 p.
artikel
1877 Prevention of H2O2-induced apoptosis in neuron-like PC12 cells by 3-Thiomethyl-5,6-(dimethoxyphenyl)-1,2,4-triazine: Role of mitogen-activated protein kinases and Heat shock proteins Tusi, Solaleh Khoramian
2011
7 4S p. S613-
1 p.
artikel
1878 Prion Mead, Simon
2011
7 4S p. S767-
1 p.
artikel
1879 Prion disease masquerading as Alzheimer's disease Thompson, Andrew
2011
7 4S p. S764-
1 p.
artikel
1880 Prion-like properties of assembled tau protein Goedert, Michel
2011
7 4S p. S485-
1 p.
artikel
1881 Prion-like properties of tau Goedert, Michel
2011
7 4S p. S86-
1 p.
artikel
1882 Prior transient ischemic attack (TIA) and early dementia after subsequent ischemic stroke Jacquin, Agnès
2011
7 4S p. S753-S754
2 p.
artikel
1883 Pro-apoptotic function of PIN1-mediated Notch1 activation Baik, Sang-Ha
2011
7 4S p. e32-
1 p.
artikel
1884 Probabilistic diffusion tractography of the corpus callosum and motor function in the elderly Silbert, Lisa
2011
7 4S p. S425-
1 p.
artikel
1885 Probabilistic diffusion tractography of the corpus callosum and motor function in the elderly Silbert, Lisa
2011
7 4S p. S69-
1 p.
artikel
1886 Profile of selective ORL1 antagonist demonstrates mechanism safe to target for symptomatic treatment in Alzheimer's Disease Duplantier, Allen
2011
7 4S p. S767-S768
2 p.
artikel
1887 Prognostic significance of florbetapir F18 PET imaging in MCI and mormal elderly: Final results from a longitudinal multicenter trial Doraiswamy, P. Murali
2011
7 4S p. S108-
1 p.
artikel
1888 Prognostic value of frontal lobe symptoms in mild cognitive impairment for conversion to Alzheimer's disease Van der Mussele, Stefan
2011
7 4S p. S547-S548
2 p.
artikel
1889 Progranulin gene therapy prevents plaque formation and synapse loss in a rodent model of AD Van Kampen, Jackalina
2011
7 4S p. e7-e8
nvt p.
artikel
1890 Progranulin regulates neuronal morphology through activation of ERK pathway Gass, Jennifer
2011
7 4S p. S686-
1 p.
artikel
1891 Progress in CSF biomarker discovery for mild cognitive impairment and Alzheimer's Disease by label-free quantitative proteomics Chasserini, Davide
2011
7 4S p. S675-
1 p.
artikel
1892 Progression of Alzheimer's disease pathology in hypercholesterolemia rabbits Woodruff-Pak, Diana S.
2011
7 4S p. S126-S127
2 p.
artikel
1893 Progression of MRI markers and decline of cognitive performance over 10 years the 3C-MRI-Dijon study Godin, Ophélia
2011
7 4S p. S352-
1 p.
artikel
1894 Progressive age-related impairment of the late long-term potentiation in Alzheimer's disease presenilin-1 mutant knock-in mice Auffret, Alexandra
2011
7 4S p. S531-S532
2 p.
artikel
1895 Progressive Aphasia Severity Scale: Baseline and longitudinal measures in PPA and relationship to quantitative imaging biomarkers Sapolsky, Daisy
2011
7 4S p. S762-
1 p.
artikel
1896 Progressive pre-dementia cognitive impairment is predicted by baseline increase of MRI radial diffusion Selnes, Per
2011
7 4S p. S725-
1 p.
artikel
1897 Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system Yang, Sujeong
2011
7 4S p. S530-S531
2 p.
artikel
1898 Prolonging safe driving in the patient with Alzheimer's disease Holland, Peter
2011
7 4S p. S782-S783
2 p.
artikel
1899 Promoting Alzheimer's disease AD information and awareness Silva, Wainer
2011
7 4S p. S641-
1 p.
artikel
1900 Pro-neurotrophin receptor sortilin in neurodegenerative processes and Alzheimer's disease Carlo, Anne-Sophie
2011
7 4S p. S113-
1 p.
artikel
1901 Prospective follow-up cognitive function change between third and ninth months in post-lacunar infarct patients Chen, Chun
2011
7 4S p. S276-
1 p.
artikel
1902 Prostaglandin E2 E-prostanoid 4 receptor signaling in microglia reduces inflammation and amyloid burden in a mouse model of Alzheimer's disease Woodling, Nathan
2011
7 4S p. e12-
1 p.
artikel
1903 Protective effects of a synthetic triazine derivative against H2O2-induced PC12 cell apoptosis by preventing endoplasmic reticulum stress Ansari, Niloufar
2011
7 4S p. S608-
1 p.
artikel
1904 Protective effects of curcuminoids against beta amyloid toxicity Singh, Sajla
2011
7 4S p. S473-
1 p.
artikel
1905 Protective effects of curcumin on brain vascular dementia by chronic cerebral ischemia in rats and study of the molecular mechanism Li, Yu
2011
7 4S p. e47-e48
nvt p.
artikel
1906 Protective effects of pre--germinated brown rice extract against amyloid β-Peptide (1-42) -induced apoptosis in neuronal SK-N-SH cells Soi-ampornkul, Rungtip
2011
7 4S p. S117-
1 p.
artikel
1907 Protein expression in the brain of transgenic mice models of Alzheimer's disease Fritsch, Manuela
2011
7 4S p. S564-
1 p.
artikel
1908 Proteomic characterization of a novel rat model of Alzheimer's disease Crawford, Fiona
2011
7 4S p. S517-S518
2 p.
artikel
1909 Providing peer-based social support for caregivers of spouses with dementia using telephone conference calls McHugh, Joanna
2011
7 4S p. S437-
1 p.
artikel
1910 Proxy-rated quality of life in Alzheimer's disease: a 3-year longitudinal study Vogel, Asmus
2011
7 4S p. S641-
1 p.
artikel
1911 Pseudo-continuous arterial spin-labelling at 3T in Alzheimer disease - initial experience in a memory clinic Binnewijzend, Maja
2011
7 4S p. S713-
1 p.
artikel
1912 Psychometric evaluation of a brief, new instrument for the measurement of caregiver burden: Review of the Impact of Alzheimer's Disease on Caregiver Questionnaire Bonnet, Patrick
2011
7 4S p. S449-
1 p.
artikel
1913 Psychosis in Alzheimer disease: towards an integrated research agenda Sweet, Robert
2011
7 4S p. S91-
1 p.
artikel
1914 Psychotherapy and other supportive procedures for treating depression and anxiety in MCI Blacioti, Mona
2011
7 4S p. S534-
1 p.
artikel
1915 Pterocarpus erinaceus extract decreases β-amyloid peptide production in an in-vitro model Hage, Salim
2011
7 4S p. e59-
1 p.
artikel
1916 Pulse pressure and cognitive impairment in treated hypertensive patients Tarnovska-Kadreva, Rumiana
2011
7 4S p. S620-
1 p.
artikel
1917 Pure vascular dementia mimicking the behavioral variant of frontotemporal lobar degeneration: About 3 cases Deramecourt, Vincent
2011
7 4S p. S752-S753
2 p.
artikel
1918 Puromycin-sensitive aminopeptidase rescues β-amyloid toxicity in Alzheimer's disease Kruppa, Antonina
2011
7 4S p. S408-
1 p.
artikel
1919 Pyridin-2-ylmethylamine derivatives as novel inhibitors of aβ aggregation and toxicity Asuni, Ayodeji
2011
7 4S p. S471-S472
2 p.
artikel
1920 Pyroglutamate-targeting Aβ AFFITOPE® vaccines reached clinical testing : Rationale and State-of-the-Art Mandler, Markus
2011
7 4S p. S466-
1 p.
artikel
1921 Quality, and not just quantity, of education accounts for ethnoracial differences in neuropsychological performance in Alzheimer's disease Negash, Selamawit
2011
7 4S p. S257-S258
2 p.
artikel
1922 Quality assessment of Alzheimer's evaluation units (AEUs): a census of Italy's Lombardy region units Franchi, Carlotta
2011
7 4S p. S641-
1 p.
artikel
1923 Quality of care for dementia in primary care Connolly, Amanda
2011
7 4S p. S631-
1 p.
artikel
1924 Quality of life in dementia patients in a developing country: Comparison of three approaches Bhandari, R.P.
2011
7 4S p. S638-
1 p.
artikel
1925 Quality of Life of People with Dementia Living in Residential Care Facilities: the Dementia in Residential Care Education Intervention Trial (DIRECT) Study Beer, Christopher
2011
7 4S p. S292-
1 p.
artikel
1926 Quantification of beta-amyloid ï€ peptides in dog CSF following gamma-secretase modulator and inhibitor treatment Barao, Ana
2011
7 4S p. S455-S456
2 p.
artikel
1927 Quantification of plasma p3-Alca level with sELISA systems Fang, Jia
2011
7 4S p. S577-
1 p.
artikel
1928 Quantifying translocator protein (TSPO) in Alzheimer's disease and cognitively healthy older persons with 11C-DPA-713 PET imaging Rosenberg, Paul
2011
7 4S p. S725-
1 p.
artikel
1929 Quantitation of beta-amyloid in transgenic mice using whole slide digital imaging and image analysis software Dunstan, Robert
2011
7 4S p. S700-
1 p.
artikel
1930 Quantitation of plasma Abeta40 and Abeta42 levels using rabbit monoclonal antibodies Mehta, Pankaj D.
2011
7 4S p. S142-
1 p.
artikel
1931 Quantitative and qualitative analysis of clustering and switching in elderly individuals Giacominelli, Carla
2011
7 4S p. S245-
1 p.
artikel
1932 Quantitative determination of TDP-43 in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and other neurodegenerative disorders Hosokawa, Masato
2011
7 4S p. S138-
1 p.
artikel
1933 Quantitative modeling of amyloidogenic processing and its influence by SORLA/SORL1 in AlzheimerÂś disease Schmidt, Vanessa
2011
7 4S p. S410-
1 p.
artikel
1934 Quantitative SPECT characteristics of Alzheimer's disease, mild cognitive impairment with comparison of neurophsychologic test battery Yalin, Osman Özgür
2011
7 4S p. S345-S346
2 p.
artikel
1935 Quantitative SPECT characteristics of frontotemporal dementia: Preliminary reports Yalın, Osman Özgür
2011
7 4S p. S277-
1 p.
artikel
1936 Quinolinic acid in HIV-1-associated dementia with pathogenetic processes distinct from Alzheimer disease Wu, Wei
2011
7 4S p. S710-
1 p.
artikel
1937 Racial differences in the recognition of cognitive dysfunction in older persons Kornsey, Erin
2011
7 4S p. S440-
1 p.
artikel
1938 Racial disparities in a community-based sample of a novel memory screening protocol Kornsey, Erin
2011
7 4S p. S613-
1 p.
artikel
1939 Racial/Ethnic group differences in the association of APOE ϵ4 Genotype and visuospatial test performance in a non-demented sample Pavlik, Valory
2011
7 4S p. S361-
1 p.
artikel
1940 RAGE and LRP1 modulation in TgCRND8 mice under condition of B-vitamin deficiency Nicolia, Vincenzina
2011
7 4S p. S580-
1 p.
artikel
1941 RanBP10, a homologue of the Alzheimer’s-associated protein RanBP9, disrupts cell adhesion and migration but fails to promote amyloid beta peptide generation Woo, Jung A.
2011
7 4S p. S118-
1 p.
artikel
1942 RanBP9 promotes mitochondrial dysfunction and calcium deregulation in primary neurons Roh, Seung-Eon
2011
7 4S p. S570-
1 p.
artikel
1943 Randomized controlled trial for treatment of apathy in Alzheimer's disease Padala, Prasad
2011
7 4S p. S300-
1 p.
artikel
1944 Randomized controlled trial of memantine for agitation in dementia Fox, Chris
2011
7 4S p. e56-
1 p.
artikel
1945 Rapamycin treatment reverses memantine-mediated increase in synaptic signaling proteins in degenerating primary neurons: Implications in Alzheimer's disease Lahiri, Debomoy
2011
7 4S p. S656-
1 p.
artikel
1946 Rare Genetic Variants in APP, PSEN1, PSEN2, GRN, APOE and MAPT Associated with CSF Aß and tau/ptau181 Levels in Patients with Late-Onset Alzheimer’s Disease Benitez, Bruno
2011
7 4S p. S179-
1 p.
artikel
1947 RAR, RXR and PPAR Expression Profiles in Peripheral Blood Mononuclear Cells are Associated with Cognitive Performances of Free-Living Older Persons: The COGINUT Study Feart, Catherine
2011
7 4S p. S184-S185
2 p.
artikel
1948 Rate of death among family members predicts risk of Alzheimer's disease and other dementias: The Cache County study Norton, Maria
2011
7 4S p. S599-
1 p.
artikel
1949 Reading the mind in the eyes test for detection of social cognition deficit in patients with mild cognitive impairment: Discriminative validity and ROC curve Rojas, Galeno
2011
7 4S p. S262-
1 p.
artikel
1950 Realistic sample size estimates for longitudinal imaging biomarkers in ADNI Holland, Dominic
2011
7 4S p. S137-S138
2 p.
artikel
1951 Receptor occupancy of the 5-HT6 receptor antagonist SAM-760 in non-human primates and healthy human volunteers Comery, Thomas
2011
7 4S p. S794-S795
2 p.
artikel
1952 Recognition of facial expression and emotional prosody in Alzheimer's disease Costa, Hélida
2011
7 4S p. S241-
1 p.
artikel
1953 Recovery as well as prevention of memory loss in aging and Alzehimer's disease by targeted expression of a RGS14 protein Navarro-Lobato, Irene
2011
7 4S p. S770-
1 p.
artikel
1954 Recruitment of nursing students into gerontological mental health nursing: Facilitating and constraining factors Le Navenec, Carole
2011
7 4S p. S634-
1 p.
artikel
1955 Reduced cerebrovascular tight junction integrity in Alzheimer's disease is directly linked to hypervascularity and angiogenesis Biron, Kaan
2011
7 4S p. e21-
1 p.
artikel
1956 Reduced microstructural integrity of white matter in non-demented elderly subjects with increased levels of systemic inflammation Arfanakis, Konstantinos
2011
7 4S p. S203-S204
2 p.
artikel
1957 Reduced regional gray matter in cognitively normal young adults at genetic risk for early-onset Alzheimer's disease Fleisher, Adam
2011
7 4S p. S48-
1 p.
artikel
1958 Reduced regional gray matter in cognitively normal young adults at genetic risk for early-onset Alzheimer's disease Fleisher, Adam
2011
7 4S p. S232-
1 p.
artikel
1959 Reducing epileptiform activity by levetiracetam rescues synaptic and cognitive functions in a mouse model of Alzheimer's disease Sanchez, Pascal
2011
7 4S p. S664-
1 p.
artikel
1960 Reducing Stress and Burden of Family Caregivers: Empirical Findings and New Directions Zarit, Steven
2011
7 4S p. S278-
1 p.
artikel
1961 Reduction of beta-amyloid accumulation by reticulon 3 in transgenic mice Araki, Wataru
2011
7 4S p. S412-S413
2 p.
artikel
1962 Reduction of Tau phosphorylation via novel OGA inhibitors Horne, Graeme
2011
7 4S p. S571-
1 p.
artikel
1963 Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease O'Bryant, Sid
2011
7 4S p. S325-
1 p.
artikel
1964 Refinement of pharmacologic MRI as a probe of in vivo cholinergic function Fong, Tamara
2011
7 4S p. S716-S717
2 p.
artikel
1965 Refining perspectives of memory loss in dementia: The memory access hypothesis Sinclair, Karen
2011
7 4S p. S646-
1 p.
artikel
1966 Regional brain perfusion correlates of visuospatial impairment in dementia with Lewy bodies, Parkinson's disease with dementia and Alzheimer's disease Kramberger, Milica G.
2011
7 4S p. S757-
1 p.
artikel
1967 Regional correspondence of ante-mortem and post-mortem amyloid load Price, Julie
2011
7 4S p. S219-
1 p.
artikel
1968 Regional correspondence of antemortem and postmortem amyloid load Price, Julie
2011
7 4S p. S34-
1 p.
artikel
1969 Regional functional connectivity changes in AD and MCI: dual regression applied to resting state fMRI Binnewijzend, Maja
2011
7 4S p. S205-
1 p.
artikel
1970 Regionalization of the distribution of APPcc and SET in the hippocampus of Alzheimer's patients Facchinetti, Patricia
2011
7 4S p. S684-
1 p.
artikel
1971 Regulation of the amyloid precursor protein processing by the Nuclear Factor-kappa B Chami, Linda
2011
7 4S p. S383-
1 p.
artikel
1972 Regulatory considerations Isaac, Maria
2011
7 4S p. S811-
1 p.
artikel
1973 Relating memory to functional capacity from normal aging to dementia using hierarchical Bayesian cognitive processing models Shankle, William
2011
7 4S p. S265-
1 p.
artikel
1974 Relational factors of subjective well-being in old age Moraru, Raluca
2011
7 4S p. S257-
1 p.
artikel
1975 Relation of Alzheimer’s Disease and CVD Pathology on the Expression of Cognitive Impairment Bennett, David
2011
7 4S p. S284-
1 p.
artikel
1976 Relation of late-life depression with MCI and dementia: Early symptom or risk factor? Richard, Edo
2011
7 4S p. S600-S601
2 p.
artikel
1977 Relation of linear measures of atrophy, burden and topography of cerebral microbleeds and white matter hyperintensities with cognitive function in adults with otherwise normal MRI Topcuoglu, Esen Saka
2011
7 4S p. S222-S223
2 p.
artikel
1978 Relationship between APOE-genotype and neurodegenerative brain pathologies, as assessed by neuroimaging procedures Drzezga, Alexander
2011
7 4S p. S90-
1 p.
artikel
1979 Relationship between Apolipoprotein E gene polymorphism and mild cognitive impairment among the patients with type 2 diabetes mellitus Xie, Yun
2011
7 4S p. S198-S199
2 p.
artikel
1980 Relationship between caregiver engagement and severity of cognitive impairment in early Alzheimer's Disease (AD) Burns, Leah
2011
7 4S p. S428-S429
2 p.
artikel
1981 Relationship between cerebral amyloid angiopathy and white matter hyperintensities in demented and nondemented subjects Raniga, Parnesh
2011
7 4S p. S301-S302
2 p.
artikel
1982 Relationship between cerebral glucose metabolism and [C-11]BF-227 accumulation in the stages from cognitively normal to Alzheimer's disease Ito, Kengo
2011
7 4S p. e43-
1 p.
artikel
1983 Relationship between cognition and fear of falling Van der Meer, Adriana
2011
7 4S p. S367-
1 p.
artikel
1984 Relationship between depression and CSF markers in Alzheimer's disease and mild cognitive disorder Aarsland, Dag
2011
7 4S p. S128-
1 p.
artikel
1985 Relationship between expectancy/credibility and early response to telephone-based dementia caregiver interventions Tremont, Geoffrey
2011
7 4S p. S435-
1 p.
artikel
1986 Relationship between heat shock protein 70 and β amyloid in patients with Alzheimer's disease and vascular dementia Fu, Yi
2011
7 4S p. S136-
1 p.
artikel
1987 Relationship between MRI findings, medical background and response to cerebrolysin in Alzheimer's disease patients: results from the Argentinean Cerebrolysin Registry Kremer, Janus
2011
7 4S p. S346-
1 p.
artikel
1988 Relationship between orthostatic hypotension and cognitive impairment in the elderly Labouree, Florian
2011
7 4S p. S597-
1 p.
artikel
1989 Relationship between patient dependence on others and clinical measures of cognition, function and behavior in Alzheimer's disease (AD): Results from a longitudinal study Lacey, Loretto
2011
7 4S p. S644-
1 p.
artikel
1990 Relationship Between TOMM40 and APOE Genotypes in the Wisconsin Registry for Alzheimer’s Prevention (WRAP) Sager, Mark
2011
7 4S p. S194-
1 p.
artikel
1991 Relationship of functional activation deficit and anatomical atrophy in the primary olfactory cortex and hippocampus of Alzheimer's disease Wang, Jianli
2011
7 4S p. e42-e43
nvt p.
artikel
1992 Relationship of tumor-promoting factors LAPTM4B and alzheimer's disease pathologies Li, Chuitxia
2011
7 4S p. S556-S557
2 p.
artikel
1993 Relationships between metabolic syndrome and cognitive functions in South Korea Kang, Sunggoo
2011
7 4S p. e18-
1 p.
artikel
1994 Relevance of the interaction between SORLA and cytosolic adaptor proteins for amyloidogenic processing Burgert, Tilman
2011
7 4S p. S579-S580
2 p.
artikel
1995 Reliability and sensitivity to detect cortical cholinergic denervation in rats using PET imaging with [18F]Fluoroethoxybenzovesamicol Parent, Maxime
2011
7 4S p. S34-
1 p.
artikel
1996 Reliability and validity of a self-report questionnaire to measure physical activity in people with mild cognitive impairment Kirk-Sanchez, Neva
2011
7 4S p. S453-
1 p.
artikel
1997 Reliability of the Canadian occupational performance measure in Brazilian older adults with mild cognitive impairment de Fátima dos Santos Chaves, Giseli
2011
7 4S p. S156-S157
2 p.
artikel
1998 Renal function outcome after lithium therapy for cognitive decline Aprahamian, Ivan
2011
7 4S p. S480-
1 p.
artikel
1999 Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Clinical validation in Greece Petsanis, Konstantinos
2011
7 4S p. e45-
1 p.
artikel
2000 Repeated baseline cognitive measurements in mild to moderate AD patients reveal significant day-to-day variation Zettergren, Annica
2011
7 4S p. e64-
1 p.
artikel
                             2578 gevonden resultaten
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland